🫀

PA Cardiology — Interactive Dashboard

Hypertension · Coronary Artery Disease · Heart Failure · Cardiomyopathies
2025 AHA/ACC Blood Pressure Classification
Normal
<120/80
Elevated
120-129/<80
Stage 1
130-139/80-89
Stage 2
≥140/≥90
Crisis
>180/>120
CategorySystolicDiastolicAction
Normal<120<80Encourage healthy lifestyle
Elevated120–129<80Lifestyle modification only
Stage 1 HTN130–13980–89Lifestyle ± meds if CVD risk ≥10%
Stage 2 HTN≥140≥90Lifestyle + medications
HTN Crisis>180>120Urgency vs Emergency — see below
⭐ High YieldTreatment threshold changed in 2025: Stage 1 HTN now treated at 130/80 if 10-yr ASCVD risk ≥10%. White coat HTN: elevated in office, normal at home. Masked HTN: normal in office, elevated at home (worse prognosis).

Primary vs Secondary HTN

Primary (Essential)Secondary
Frequency90–95%5–10%
Onset30–50s, gradualAny age, abrupt
Family HxOften +Usually –
CausesGenetics, diet, obesityRenovascular, PA, OSA, renal disease, pheochromocytoma, coarctation, thyroid
Screen for secondary HTN if: Age <30, sudden onset, resistant to 3+ meds, hypokalemia (think primary aldosteronism), or episodic hypertension + headache + sweating (pheochromocytoma).

HTN Urgency vs Emergency

UrgencyEmergency
BP>180/120>180/120
End-Organ DamageNoneYES
SymptomsHA, anxietyChest pain, SOB, neuro changes, papilledema
GoalReduce 25% over 24–48h (outpatient)Reduce 25% in 1h (IV meds, ICU)
TreatmentOral labetalol, amlodipine, captoprilIV labetalol, nitroprusside, nicardipine
⚠️ DO NOT drop BP too fast in HTN emergency → risk of watershed infarction, AKI.
First-Line Treatment by Population
PopulationPreferred Agent(s)Why
General (non-Black)Thiazide, ACEi/ARB, CCBEqual first-line efficacy
Black patientsThiazide + CCBACEi/ARB less effective monotherapy (low renin)
DiabetesACEi or ARBRenoprotective, reduce proteinuria
CKDACEi or ARBNephroprotection
HFrEFARNI + BB + MRA + SGLT2i (GDMT)Mortality benefit
Post-MIBB + ACEi/ARB + StatinReduce remodeling, mortality
Angina (CAD)BB (first-line antianginal) or CCBReduce myocardial O₂ demand
BPHAlpha-blocker (terazosin, doxazosin)Treats both BPH and HTN
PregnancyMethyldopa, labetalol, nifedipineSafe for fetus; ACEi/ARB CONTRAINDICATED
⭐ High YieldACEi + ARB = never combine (↑risk of AKI, hyperkalemia). ACEi/ARB: CONTRAINDICATED in pregnancy (teratogenic — bilateral renal agenesis). ACEi side effect: dry cough → switch to ARB.
Lifestyle Modifications (Non-Pharmacologic)
DASH Diet
↓BP by ~8–14 mmHg. Low sodium (<2.4g/day), high K+, Ca2+, Mg2+, fruits, vegetables.
Exercise
Aerobic 90–150 min/week. ↓BP by ~5–8 mmHg.
Weight Loss
↓1 kg → ↓BP ~1 mmHg. Goal BMI <25.
Limit Alcohol
Men ≤2 drinks/day; Women ≤1/day.
Stop Smoking
Major CV risk reduction. Varenicline or NRT.
Reduce Na+
Goal <1.5g/day for best effect.
Atherosclerosis Pathophysiology
Pathogenesis: Endothelial injury (from HTN, smoking, DM, dyslipidemia) → LDL enters intima → oxidized → macrophages engulf → foam cells → fatty streak → fibrous plaque → vulnerable plaque (thin cap, lipid core) → RUPTURE → thrombus → ACS.
⭐ Key ConceptStable plaque = thick fibrous cap, smaller lipid core. Vulnerable plaque = thin cap, large lipid core. ACS caused by PLAQUE RUPTURE, not just stenosis. A 40% stenotic plaque can rupture and cause MI!
HEART Score (ED Risk Stratification)
Component012
HistorySlightly suspiciousModerately suspiciousHighly suspicious
EKGNormalNon-specific repolarizationSignificant ST deviation
Age<4545–64≥65
Risk FactorsNo known risk factors1–2 risk factors≥3 risk factors or atherosclerosis
Troponin≤normal limit1–3x normal>3x normal
Low (0–3)
0.9–1.7% MACE. Safe discharge, outpatient follow-up.
Moderate (4–6)
12–16.6% MACE. 6h observation, serial troponins.
High (7–10)
50–65% MACE. Admit, early invasive strategy.

Stable Angina

Symptoms: Exertional chest pressure/pain, relieved by rest or nitroglycerin in <5 min. Predictable pattern.

Classic presentation: Substernal pressure radiating to L arm/jaw, brought on by exertion, relieved by rest.

Anti-anginal hierarchy:

  1. Beta-blockers — first-line (↓HR, ↓O₂ demand)
  2. CCB — if BB contraindicated or as add-on
  3. Long-acting nitrates — add-on therapy (nitrate-free interval required!)
  4. Ranolazine — late Na+ channel blocker, add-on
⭐ Stable CAD TreatmentASA 81mg + Statin + BB (antianginal) + ACEi + sublingual NTG PRN. NTG: max 3 doses q5min, call 911 if no relief after first dose in suspected ACS.

Vasospastic (Prinzmetal's) Angina

Pathophysiology: Transient coronary artery spasm → transmural ischemia

FeatureDetails
TimingAt REST, early morning (2–8 AM)
EKG during episodeST ELEVATION (transient)
Coronary anatomyNormal or near-normal on angiography
AssociatedSmoking, cocaine use, hyperventilation
Provocative testErgonovine challenge
✅ TREAT: CCBs (first-line!), Long-acting nitrates
❌ AVOID: Beta-blockers (can worsen spasm via unopposed alpha stimulation), ASA (high dose).
Acute Coronary Syndromes (ACS)

Unstable Angina (UA)

Troponin: Normal
EKG: ST depression/T-wave inversion or normal
Pattern: New onset, rest angina, crescendo angina
Pathology: Plaque rupture + partial thrombus

NSTEMI

Troponin: ✅ Elevated
EKG: ST depression, T-wave inversion, or normal
NO ST elevation
Pathology: Plaque rupture + partial thrombus

STEMI

Troponin: ✅ Elevated
EKG: ≥1mm ST elevation in 2+ contiguous leads, or new LBBB
Pathology: Complete occlusion, transmural ischemia

⭐ Key Troponin PointsTroponin rises 3–6h after onset, peaks at 12–24h. Use high-sensitivity troponin (serial at 0h and 3h). Troponin can also rise in PE, myocarditis, SIADH, demand ischemia (type 2 MI). UA vs NSTEMI: TROPONIN is the differentiator.

ACS Initial Management — MONA + BASH

MONA (Immediate)

M
Morphine — for pain (if no response to NTG); use cautiously
O
Oxygen — only if SpO₂ <90%! Don't give O₂ routinely
N
Nitrates — SL NTG q5 min x3; avoid if RV infarct, PDE5i use, hypotension
A
Aspirin — 325mg non-enteric coated, chew immediately

BASH (Add-On)

B
Beta-blocker — IV metoprolol if tachycardic/hypertensive (avoid if HF, bradycardia, shock)
A
Anticoagulation — IV heparin (UFH or LMWH)
S
Statin — high-intensity: atorvastatin 80mg or rosuvastatin 40mg immediately
H
Heparin + P2Y12 — ticagrelor (preferred) or clopidogrel + heparin
STEMI Territories (EKG Localization)

🔴 Anterior

Artery: LAD
Leads: V1–V4
Reciprocal: aVL (lateral)
Complications: HF, cardiogenic shock, LBBB

🟢 Inferior

Artery: RCA (85%) or LCx (15%)
Leads: II, III, aVF
Reciprocal: I, aVL
Get right-sided leads! (RV infarct)

🔵 Lateral

Artery: LCx
Leads: I, aVL, V5, V6
Reciprocal: II, III, aVF
Often with anterior/inferior

🟠 Posterior

Artery: LCx or RCA
Leads: V7–V9 (posterior leads)
Reciprocal: V1–V3 ST DEPRESSION
R-wave dominant in V1–V2

🟣 Right Ventricle

Artery: RCA
With inferior STEMI
Leads: V1, V4R
Avoid nitrates + diuretics! Give fluids.

✅ STEMI Treatment

PCI within 90 min (door-to-balloon)
If no PCI: Thrombolytics within 12h if door-to-balloon >120min
Absolute CI to lytics: Prior ICH, active bleed, BP >185/110

⚠️ Cocaine-Induced MI: Give phentolamine (alpha-blocker) or benzodiazepines. AVOID β-blockers — causes unopposed α-stimulation → worsens vasoconstriction!
DAPT (Dual Antiplatelet Therapy) Duration
ScenarioRegimenDuration
Stable CAD, medical managementASA 81mg aloneIndefinite
Stable CAD, BMS (bare metal stent)ASA 81mg + Clopidogrel≥1 month
Stable CAD, DES (drug eluting stent)ASA 81mg + Clopidogrel6–12 months
ACS (any type)ASA 81mg + Ticagrelor (preferred) or Prasugrel≥12 months
ACS + high bleed riskASA 81mg + Clopidogrel6–12 months
⭐ P2Y12 Hierarchy in ACSTicagrelor > Prasugrel > Clopidogrel. Prasugrel: AVOID if prior TIA/stroke, age ≥75, weight <60kg. Clopidogrel: prodrug requiring CYP2C19 metabolism (poor metabolizers respond less). After PCI: NEVER stop DAPT early without cardiology consult (in-stent thrombosis risk).
HFrEF vs HFpEF
FeatureHFrEF (Systolic)HFpEF (Diastolic)
EF<40% (reduced)≥50% (preserved)
HFmrEFEF 41–49% — mildly reduced
ProblemCan't squeeze (systolic dysfunction)Can't fill (diastolic dysfunction, stiff ventricle)
Common causesCAD/MI, DCM, viral myocarditis, EtOH, doxorubicinHTN (most common), obesity, DM, AF, aging
Mortality benefit medsARNI, BB, MRA, SGLT2i (4 pillars)SGLT2i (only proven mortality benefit)
ImagingDilated LV, thin wallsNormal/small LV, thick walls (concentric hypertrophy)
Clinical Presentation

Left-Sided HF (Forward Failure → Backup into lungs)

  • Dyspnea on exertion (earliest symptom)
  • Orthopnea (# pillows to breathe)
  • Paroxysmal Nocturnal Dyspnea (PND)
  • Bilateral crackles/rales
  • S3 gallop (volume overload — "Ken-tuc-ky")
  • Pulsus alternans
  • Cardiomegaly on CXR
  • Kerley B lines, pulmonary edema on CXR

Right-Sided HF (Backup into systemic circulation)

  • JVD (jugular venous distension)
  • Hepatomegaly, hepatojugular reflux
  • Ascites
  • Peripheral pitting edema (bilateral)
  • Kussmaul sign (JVD worsens with inspiration)
  • S3 right-sided
  • Most common cause of right HF: LEFT HF

BNP / NT-proBNP

MarkerCutoff (Likely HF)Cutoff (Unlikely HF)
BNP>100 pg/mL<35 pg/mL
NT-proBNP>300 pg/mL (any age)<125 pg/mL
Note: BNP falsely LOW in obesity. BNP elevated in PE, renal failure, sepsis. NT-proBNP age-adjusted for ED diagnosis: <50yo: >450; 50–75yo: >900; >75yo: >1800 pg/mL.

Framingham Criteria (need 2 Major OR 1 Major + 2 Minor)

Major Criteria:

  • Paroxysmal nocturnal dyspnea (PND)
  • Neck vein distension (JVD)
  • Rales
  • Cardiomegaly on CXR
  • Acute pulmonary edema
  • S3 gallop
  • Elevated CVP (>16 cmH₂O)
  • Hepatojugular reflux (HJR)
  • Weight loss >4.5kg in 5 days on treatment

Minor Criteria:

  • Bilateral ankle edema
  • Nocturnal cough
  • Dyspnea on exertion
  • Hepatomegaly
  • Pleural effusion
  • Tachycardia (>120 bpm)
  • Decrease in vital capacity by 1/3 from max
Classification Systems

NYHA Functional Classification

ClassSymptoms
INo limitation; ordinary activity doesn't cause symptoms
IISlight limitation; comfortable at rest, ordinary activity → symptoms
IIIMarked limitation; comfortable at rest, less than ordinary activity → symptoms
IVUnable to carry on any activity without discomfort; symptoms AT REST

ACC/AHA Staging (A → D, irreversible)

StageDescription
AAt HIGH RISK for HF; no structural disease, no symptoms (DM, HTN, CAD)
BStructural heart disease; no HF symptoms (asymptomatic LVH, prior MI)
CStructural disease + current or prior HF symptoms (most HF patients)
DRefractory HF; advanced therapy needed (transplant, LVAD, palliation)
⭐ Key DifferenceNYHA = symptom severity (can go up or down). ACC/AHA Stage = disease progression (only goes forward, never backward).
GDMT — Guideline-Directed Medical Therapy for HFrEF (EF <40%)

PILLAR 1
ARNi / ACEi / ARB

Sacubitril/valsartan (Entresto) — preferred
If not tolerated: ACEi or ARB
↓Mortality ~20%

PILLAR 2
Beta-Blocker

Carvedilol (α+β)
Metoprolol succinate (β1)
Bisoprolol (β1)
ONLY these 3 have mortality benefit!

PILLAR 3
MRA

Spironolactone or Eplerenone
↓Mortality, ↓hospitalization
Monitor K+; use if K+ <5.0, eGFR >30

PILLAR 4
SGLT2i

Dapagliflozin or Empagliflozin
↓Hospitalization and mortality
Regardless of DM status!

⭐ Additional HFrEF AgentsIvabradine (Corlanor): HR >70 on max β-blocker, EF ≤35%, sinus rhythm. Vericiguat: Recent hospitalization, adds to GDMT. Hydralazine + Isosorbide dinitrate: If ACEi/ARB/ARNI not tolerated OR Black patients with persistent symptoms. Diuretics (furosemide): NOT proven to reduce mortality but essential for symptom relief (preload).
Device Therapy: ICD if EF ≤35% after ≥3 months GDMT. CRT if EF ≤35% + LBBB + QRS ≥150ms. LVAD for Stage D awaiting transplant.

HFpEF Management (EF ≥50%)

✅ Proven Benefit:

  • SGLT2i — Only proven mortality benefit in HFpEF (empagliflozin, dapagliflozin)
  • Diuretics — for symptom relief (edema, dyspnea)
  • Treat underlying HTN aggressively
  • Treat AFib (rate control)
  • Weight loss if obese
  • Exercise rehabilitation

❌ Not Proven in HFpEF:

  • ACEi/ARB — no mortality benefit (may help symptoms)
  • Beta-blockers — no proven mortality benefit
  • MRA — equivocal data
  • ARNI — not yet proven (trials ongoing)
  • Digoxin — not indicated
Cardiomyopathy Overview
TypeMorphologyFunctionKey CausesTreatment
Dilated (DCM)Dilated chambers, thin walls↓EF (systolic dysfunction)Idiopathic, EtOH, viral, peripartum, doxorubicin, cocaine, hemochromatosisGDMT for HFrEF
Restrictive (RCM)Normal or slightly enlarged, thick/stiffNormal EF, ↓fillingAmyloidosis, sarcoidosis, hemochromatosis, radiationDiuretics, treat cause; tafamidis for ATTR
Hypertrophic (HCM)Asymmetric septal hypertrophy, small cavityHyperdynamic EF, LVOTOGenetic — AD sarcomere mutations (MYH7, MYBPC3)BB or verapamil, mavacamten (Camzyos), ICD
TakotsuboApical ballooning, normal baseTransient ↓EFEmotional/physical stress; post-menopausal womenSupportive; usually self-limiting; avoid catecholamines

Hypertrophic Cardiomyopathy (HCM/HOCM)

⭐ #1 Cause of Sudden Cardiac Death in Young Athletes

Classic triad: Exertional syncope, angina, palpitations

Murmur: Harsh systolic crescendo-decrescendo at LLSB

ManeuverEffect on LVOTOMurmur
Valsalva (strain phase)↓Preload → WORSE obstructionLOUDER
Standing up↓Preload → WORSELOUDER
Squatting↑Preload → BETTERSofter
Lying flat (passive leg raise)↑Preload → BETTERSofter
Handgrip↑Afterload → BETTERSofter

Memory Trick

HOCM murmur = OPPOSITE of most other murmurs. Things that ↑preload (squatting, lying down) → LESS obstruction → softer. Things that ↓preload (Valsalva, standing) → MORE obstruction → louder.

❌ AVOID: Digoxin, vasodilators (nitrates, ACEi), diuretics (↓preload worsens LVOTO), CCBs with LVOTO (except verapamil which is ↑preload). Do NOT dehydrate HCM patients!
✅ TREAT: BB (first-line), Verapamil (alternative), Mavacamten (Camzyos — new cardiac myosin inhibitor for obstructive HCM), Disopyramide (add-on). Septal myectomy or alcohol septal ablation for refractory. ICD for high-risk patients (FH sudden death, NSVT, ↓EF, severe hypertrophy >30mm).

Takotsubo (Stress) Cardiomyopathy

Also called "Broken Heart Syndrome" or apical ballooning syndrome.

FeatureDetails
DemographicsPost-menopausal women (90%)
TriggerEmotional stress (death of loved one) or physical stress (surgery, illness)
PresentationMimics anterior STEMI — chest pain, ST elevation, troponin elevation
Coronary arteriesNORMAL on angiography
EchoApical ballooning, hyperdynamic base
MechanismCatecholamine surge → stunned myocardium
PrognosisUsually resolves in weeks; recurrence 5–10%
TreatmentSupportive. BB for prevention of recurrence. Anticoagulation if apical thrombus. AVOID catecholamines (worsen).
⭐ Board PearlTroponin elevated but coronaries clean → think Takotsubo (or myocarditis). ST elevation + echo showing apical ballooning → Takotsubo not STEMI.

Dilated Cardiomyopathy (DCM) — Key Causes

Alcohol
Most common reversible cause. Improves with abstinence. Dilated, ↓EF.
Peripartum
Last month of pregnancy to 5 months postpartum. Often recovers with treatment.
Doxorubicin (Adriamycin)
Dose-dependent cardiotoxicity. Can occur years after chemo. Check ECHO before/during chemo.
Viral Myocarditis
Coxsackievirus B most common. Fever + CP + ↑troponin. MRI confirms. Supportive tx.
Hemochromatosis
Iron deposition in myocardium. Treat with phlebotomy or deferoxamine.
Thyroid Disease
Hypothyroidism → dilated CMP. Hyperthyroidism → high-output HF. Check TSH!
Antihypertensive Medications

Thiazide Diuretics

Examples: HCTZ, Chlorthalidone (preferred), Indapamide
MOA: Block Na-Cl cotransporter in DCT → ↓Na/H₂O reabsorption → ↓volume
Side Effects: Hypokalemia, hyponatremia, hyperuricemia (gout!), hyperglycemia, hypercalcemia, hyperlipidemia
Contraindications: Gout (relative), sulfa allergy
First-line HTN
Black patients preferred

ACE Inhibitors (-pril)

Examples: Lisinopril, Enalapril, Ramipril, Captopril
MOA: Block ACE → ↓Angiotensin II → vasodilation + ↓aldosterone
Side Effects: Dry cough (10–15%), angioedema (rare but serious — switch to ARB), hyperkalemia, AKI (renal artery stenosis)
Contraindications: Pregnancy (TERATOGENIC), bilateral RAS, hyperkalemia, prior angioedema
DM/CKD preferred
⛔ Pregnancy

Angiotensin Receptor Blockers (ARBs, -sartan)

Examples: Losartan, Valsartan, Olmesartan, Candesartan
MOA: Block AT1 receptor → vasodilation + ↓aldosterone (same as ACEi but NO bradykinin → NO cough)
Side Effects: Hyperkalemia, AKI, angioedema (rare), NO cough
Key: Use when ACEi not tolerated (cough). Same contraindications as ACEi including pregnancy.
DM/CKD preferred
⛔ Pregnancy

Calcium Channel Blockers (CCBs)

DHP: Amlodipine, Nifedipine, Felodipine → peripheral vasodilation (preferred for HTN)
Non-DHP: Verapamil, Diltiazem → ↓HR, ↓AV conduction + vasodilation
MOA: Block L-type Ca²⁺ channels → vasodilation + ↓cardiac contractility (non-DHP)
DHP Side Effects: Peripheral edema, reflex tachycardia, flushing
Non-DHP Side Effects: Bradycardia, constipation (verapamil), AV block
⛔ Non-DHP: avoid with BB (bradycardia/HB)

Beta-Blockers

Selective (β1): Metoprolol, Atenolol, Bisoprolol — heart-selective
Non-selective: Propranolol, Carvedilol (α+β), Labetalol (α+β, IV in HTN emergency)
MOA: Block β₁ → ↓HR, ↓contractility → ↓CO and ↓renin
Side Effects: Bradycardia, fatigue, depression, sexual dysfunction, ↑TG, ↓HDL, mask hypoglycemia signs
Contraindications: Asthma/COPD (use β1-selective), acute decompensated HF, cocaine MI, vasospastic angina, Raynaud's
HFrEF (carvedilol, metoprolol, bisoprolol ONLY)

ARNi (ARNI)

Agent: Sacubitril/Valsartan (Entresto)
MOA: Sacubitril inhibits neprilysin (↑natriuretic peptides: ANP/BNP) + Valsartan blocks AT1 receptor
Use: HFrEF — preferred over ACEi/ARB. Must washout ACEi 36h before starting.
Side Effects: Hypotension, hyperkalemia, renal dysfunction, angioedema (if overlapping with ACEi!)
First-line HFrEF (preferred over ACEi)

SGLT2 Inhibitors

Examples: Empagliflozin (Jardiance), Dapagliflozin (Farxiga), Canagliflozin
MOA: Block SGLT2 in proximal tubule → glucosuria, natriuresis, osmotic diuresis, cardioprotective (unknown full mechanism)
Use: HFrEF + HFpEF (both!), T2DM, CKD
Side Effects: UTI, genital mycotic infections (Fournier gangrene — rare), DKA (euglycemic), ↓eGFR initially
Pillar 4 of HFrEF GDMT
HFpEF (only proven mortality benefit)

Mineralocorticoid Receptor Antagonists (MRAs)

Examples: Spironolactone (Aldactone), Eplerenone (Inspra)
MOA: Block aldosterone receptor → ↓Na reabsorption, ↓K excretion (K-sparing diuretic)
Use: HFrEF, Primary aldosteronism (spironolactone), Resistant HTN, Liver cirrhosis (spiro)
Side Effects: Hyperkalemia, gynecomastia (spironolactone only), menstrual irregularities. Eplerenone more selective = fewer hormonal SE.
Contraindications: K+ ≥5.0 mEq/L, eGFR <30

Loop Diuretics

Examples: Furosemide (Lasix), Bumetanide, Torsemide
MOA: Block Na-K-2Cl cotransporter in thick ascending loop of Henle
Use: Symptom relief in HF, pulmonary edema, hypertensive urgency
Side Effects: Hypokalemia, hypomagnesemia, hyponatremia, ototoxicity (high dose IV), hyperuricemia
Key: Torsemide has better oral bioavailability than furosemide. Metolazone combined for refractory edema.

Antianginal Agents

Nitroglycerin (NTG): NO → vasodilation (venous > arterial). Short-acting SL for acute relief. Long-acting for prevention (nitrate-free interval 10–12h to prevent tolerance).
Ranolazine: Blocks late Na+ channel → ↑Ca2+ not overloaded → ↑myocardial relaxation. Add-on for refractory angina. No effect on BP/HR.
Ivabradine: If funny (If) channel blocker → ↓HR without affecting contractility or BP. Use in stable CAD if BB intolerant.
⛔ NTG: avoid within 24h of PDE5 inhibitors (sildenafil) → profound hypotension!
Antiplatelet / Anticoagulant Quick Reference
AgentClassMOAKey Points
AspirinAntiplateletIrreversible COX-1 inhibition → ↓TXA₂81mg for CVD prevention/secondary prevention. 325mg acute ACS.
ClopidogrelP2Y12 blockerIrreversible P2Y12 block. Prodrug (CYP2C19).Cheaper; poor metabolizers respond less. Hold 5d before surgery.
TicagrelorP2Y12 blockerReversible P2Y12 block (NO hepatic activation)Preferred in ACS. CI: history of ICH, severe hepatic impairment. Hold 5d pre-surgery.
PrasugrelP2Y12 blockerIrreversible P2Y12 block (more potent prodrug)Avoid: prior TIA/stroke, age ≥75, weight <60kg. Most potent P2Y12.
UFHAnticoagulantActivates antithrombin III → inhibits Xa + IIaACS, monitored by aPTT. Reversible with protamine. HIT risk.
Enoxaparin (LMWH)AnticoagulantActivates ATIII → mainly inhibits XaMonitor anti-Xa (not aPTT). Renally cleared. CI in severe renal failure. Partial reversal with protamine.
UWorld-Style Practice Questions
A 68-year-old woman with a 10-year history of type 2 diabetes and hypertension presents with a blood pressure of 156/94 mmHg on two office visits. She is currently on no medications. Her eGFR is 55 mL/min/1.73m² and urinalysis shows 2+ proteinuria. She denies chest pain, shortness of breath, or visual changes.
Q: What is the most appropriate first-line antihypertensive for this patient?
✅ ACE Inhibitor or ARB (e.g., Lisinopril or Losartan)

This patient has Stage 2 HTN, T2DM, and CKD with proteinuria. ACEi/ARBs are preferred in diabetic patients with CKD because they:
• ↓Intraglomerular pressure (dilate efferent arteriole) → slow CKD progression
• ↓Proteinuria
• Proven mortality benefit in diabetic nephropathy

Key point: Thiazides are less effective in CKD (eGFR <30 use loop diuretics). CCBs can be added as second agent. Never combine ACEi + ARB. Monitor K+ and creatinine 1–2 weeks after starting.
A 55-year-old man presents to the ED with crushing substernal chest pain radiating to his left arm for 2 hours. EKG shows 2mm ST elevation in leads V1–V4. Troponin is elevated at 4.2 ng/mL. He receives aspirin 325mg, ticagrelor, heparin drip, and sublingual nitroglycerin. His BP is 100/70 mmHg and HR is 98 bpm. The nearest PCI-capable center is 45 minutes away.
Q: What is the next most appropriate step in management?
✅ Activate cath lab and transfer for emergent PCI (door-to-balloon within 90 minutes)

This is an anterior STEMI (V1-V4 → LAD territory). Primary PCI is the preferred reperfusion strategy if achievable within 90 minutes (door-to-balloon or first-medical-contact-to-balloon).

Since the PCI center is 45 min away (total transfer time likely <120 min), transfer for PCI is appropriate.

Thrombolytics indicated if: PCI not available within 120 minutes of first medical contact AND no contraindications (no prior ICH, BP <185/110, no active bleeding).

Note: This patient has borderline hypotension — avoid additional nitrates. Do NOT give beta-blockers with hypotension. Watch for cardiogenic shock (most common complication of anterior STEMI).
A 72-year-old woman with hypertension and obesity presents with 4 months of progressive dyspnea on exertion and bilateral ankle swelling. Echo shows EF of 60%. NT-proBNP is 650 pg/mL. BNP 85 pg/mL. She has bilateral basilar crackles and 2+ pitting edema to the knees. Her BP is 148/90 mmHg.
Q: What is the diagnosis and what medication class has proven mortality benefit?
✅ HFpEF (Heart Failure with Preserved Ejection Fraction) — SGLT2 Inhibitors

HFpEF is diagnosed when: HF symptoms + signs of congestion + EF ≥50%.

This patient: Dyspnea, edema, crackles (congestion), EF 60% (preserved), NT-proBNP elevated (>300), underlying HTN (most common cause of HFpEF).

ONLY proven mortality benefit in HFpEF: SGLT2i (empagliflozin and dapagliflozin per EMPEROR-Preserved and DELIVER trials).

Management:
• SGLT2i (first-line for mortality)
• Furosemide for symptom relief
• Aggressive HTN control
• Weight loss
• Treat AFib if present

Note: ACEi, ARB, BB, MRA do NOT have proven mortality benefit in HFpEF (unlike HFrEF).
A 22-year-old college basketball player collapses during a game. He is resuscitated and brought to the ED. His father died suddenly at age 35 "from a heart problem." Exam reveals a harsh systolic murmur at the left lower sternal border that becomes louder when he stands up and softer when he squats down. Echo shows asymmetric septal hypertrophy measuring 22mm.
Q: What is the diagnosis, and which medication is the preferred initial treatment?
✅ Hypertrophic Obstructive Cardiomyopathy (HOCM) — Beta-Blocker (e.g., Metoprolol) or Verapamil

Classic HOCM presentation:
• Young athlete, exertional syncope
• Positive family history (AD inheritance — sarcomere mutations)
• Murmur LOUDER with standing/Valsalva (↓preload → worse LVOTO)
• Murmur SOFTER with squatting (↑preload → less obstruction)

Treatment:
• Beta-blocker (first-line) or Verapamil if BB not tolerated
• Mavacamten (Camzyos) — new cardiac myosin inhibitor — approved for symptomatic obstructive HCM
• ICD for prevention of SCD (this patient had SCD event!)
• Septal myectomy or alcohol septal ablation for refractory cases

AVOID: Digoxin, ACEi/ARBs, dihydropyridine CCBs, nitrates, diuretics (all worsen LVOTO by ↓preload).

This patient clearly needs an ICD given survived cardiac arrest + positive family history.
A 65-year-old man with HFrEF (EF 30%) on carvedilol, lisinopril, and furosemide presents for routine follow-up. His BP is 118/76, HR 68, and he has minimal edema. He is in sinus rhythm. Labs: K+ 4.2 mEq/L, Na+ 138, eGFR 52 mL/min/1.73m².
Q: What two additional medications should be added to optimize his HFrEF management?
✅ Switch Lisinopril to Sacubitril/Valsartan (Entresto/ARNi) AND add an SGLT2 Inhibitor (Dapagliflozin or Empagliflozin)

Current therapy: BB (carvedilol ✅), ACEi (lisinopril ✅), loop diuretic (furosemide — symptomatic only).

He is currently on 2 of 4 GDMT pillars. Missing:
Pillar 1 upgrade: ARNi (sacubitril/valsartan) has greater mortality benefit than ACEi → switch (washout ACEi 36h before starting to prevent angioedema)
Pillar 3: MRA (spironolactone) — K+ 4.2 and eGFR 52 = appropriate to add
Pillar 4: SGLT2i (dapagliflozin or empagliflozin) — indicated in all HFrEF regardless of diabetes

Also consider: EF ≤35% → evaluate for ICD eligibility (this patient: EF 30%, on GDMT — if EF remains ≤35% after 3+ months, ICD indicated for primary prevention of SCD).
A 58-year-old woman presents with chest pain that occurs exclusively at rest, typically between 2–4 AM. Each episode lasts 15–20 minutes and resolves spontaneously. She smokes 1 PPD. EKG during an episode shows transient ST elevation in leads II, III, aVF. Between episodes, EKG is normal. Coronary angiography shows no significant stenosis.
Q: What is the diagnosis and first-line treatment?
✅ Vasospastic (Prinzmetal's) Angina — Calcium Channel Blockers (e.g., Amlodipine or Diltiazem)

Key features:
• Resting chest pain (NOT exertional)
• Early morning timing (2–8 AM) — circadian variation in coronary vasomotor tone
• Transient ST elevation during episodes (looks like STEMI but resolves!)
• Normal coronary arteries on angiography
• Smoking is a major trigger (also cocaine, hyperventilation, cold exposure)

Treatment:
• CCBs (first-line!) — diltiazem or amlodipine → ↓coronary vasospasm
• Long-acting nitrates — add-on
• Smoking cessation (critical!)

AVOID:
• Beta-blockers — leave α receptors unopposed → worsen coronary spasm
• High-dose aspirin — inhibits prostacyclin (vasodilator) → can worsen spasm
Cardiology Matching Exercises

Match the Medication to its Mechanism of Action

Click a medication (left), then click its matching mechanism (right).

Sacubitril/Valsartan
Ranolazine
Ivabradine
Spironolactone
Mavacamten
Blocks If (funny) channel → ↓HR only
Inhibits neprilysin + blocks AT1 receptor
Cardiac myosin inhibitor — ↓LVOTO in HCM
Blocks late Na+ channel → ↓Ca2+ overload
Blocks aldosterone receptor → K+ retention

Match the STEMI Territory to the Coronary Artery

V1–V4 ST elevation
II, III, aVF ST elevation + V4R changes
I, aVL, V5, V6
V1–V3 ST depression (reciprocal only)
RCA → inferior STEMI + RV infarct
Posterior STEMI (LCx/RCA) — get posterior leads
LAD → anterior STEMI
LCx → lateral STEMI

Match the HF Medication to its Indication/Role

Furosemide
Ivabradine
Hydralazine + Isosorbide Dinitrate
Carvedilol
Tafamidis
HFrEF + HR >70 on max β-blocker, sinus rhythm
α+β blocker — one of 3 BB with HFrEF mortality benefit
Transthyretin amyloid cardiomyopathy (ATTR)
Symptom relief only — NO mortality benefit in HF
HFrEF if ACEi/ARB/ARNI not tolerated OR Black patients
0/0
Questions answered correctly
Click choices, then "Check Answer"
EKG Rhythm Recognition — 15 Questions

Q1 of 15 — What rhythm is shown?

📋 Key features: Rate 72/min · Regular R-R intervals · Upright P wave before every QRS · PR interval 160ms · Narrow QRS <80ms · Normal T waves
✅ A) Normal Sinus Rhythm (NSR)

Criteria for NSR: (1) Regular P waves at rate 60-100 bpm, (2) P wave upright in II, inverted in aVR, (3) Normal PR interval 120-200ms, (4) Every P followed by QRS, (5) Narrow QRS <120ms. Rate 72 = normal (60-100). PR 160ms = normal. Everything is within normal limits. Remember: No P wave → not sinus. Irregular → think AFib or PACs. Rate >100 → sinus tachycardia. Rate <60 → sinus bradycardia.

Q2 of 15 — What rhythm is shown?

📋 Key features: Rate 130/min · Regular · P wave before every QRS · Narrow QRS · Short TP interval (P waves may appear to "ride" the T waves at higher rates)
✅ B) Sinus Tachycardia

Rate 100-150 bpm + normal P waves before every QRS = Sinus Tachycardia. Distinguishing from SVT: sinus tach has visible upright P waves (not buried/retrograde), gradual onset/offset, and commonly has an underlying cause (fever, pain, anxiety, hypovolemia, hypoxia, PE, anemia, medications). Clinical pearl: Sinus tachycardia is a RESPONSE — always find the cause. Treatment = treat the cause, NOT the rhythm itself. Never cardiovert sinus tachycardia!

Q3 of 15 — What rhythm is shown?

📋 Key features: Rate 42/min · Regular · Normal P wave before each QRS · Normal PR interval · Narrow QRS · Long R-R intervals
✅ C) Sinus Bradycardia

Rate <60 + normal P before every QRS = Sinus Bradycardia. Common causes: athletes (physiologic), vagal tone, hypothyroidism, hypothermia, inferior MI (RCA supplies SA node), medications (β-blockers, CCBs, digoxin, amiodarone). Symptomatic bradycardia (AMS, hypotension, CP, acute HF) → ACLS bradycardia algorithm: Atropine 0.5mg IV first, then TCP or dopamine/epinephrine drip if atropine fails. Key differentiator from 3rd degree block: Every P is followed by a QRS with constant PR interval.

Q4 of 15 — What rhythm is shown?

📋 Key features: Irregularly IRREGULAR rhythm · No distinct P waves · Fine fibrillatory baseline · Narrow QRS complexes at variable intervals · No consistent R-R pattern
✅ A) Atrial Fibrillation

Classic triad: (1) Irregularly irregular rhythm, (2) No distinct P waves (replaced by chaotic fibrillatory baseline), (3) Narrow QRS (unless aberrant conduction or WPW). Most common sustained arrhythmia. Management: Unstable → synchronized cardioversion. Stable → rate control (BB or diltiazem). CHA₂DS₂-VASc ≥2 → anticoagulation (DOACs preferred: apixaban, rivaroxaban, dabigatran). Don't confuse with: MAT has 3+ distinct P wave morphologies; Flutter has regular sawtooth waves; frequent PACs still has underlying sinus P waves with normal beats between ectopics.

Q5 of 15 — What rhythm is shown?

📋 Key features: Regular sawtooth-pattern between QRS complexes · Atrial rate ~300/min · Ventricular rate ~150/min · 2:1 block · Narrow QRS · Best seen in inferior leads (II, III, aVF)
✅ C) Atrial Flutter with 2:1 block

Classic features: Sawtooth flutter waves (F waves) at 300 bpm. AV node usually conducts every 2nd (2:1 → rate 150), 3rd (3:1 → rate 100), or 4th wave (4:1 → rate 75). Clinical pearl: Unexplained rate of exactly 150 bpm → think flutter with 2:1 block! Look for "hidden" flutter waves in the T waves or ST segment. Can look like sinus tach. Get vagal maneuvers or adenosine to slow the rate and reveal flutter waves. Management same as AFib (rate control, anticoagulation, cardioversion if unstable).

Q6 of 15 — What rhythm is shown?

📋 Key features: Rate 185/min · Regular · Narrow QRS complexes · No visible P waves (buried in QRS or just after) · Abrupt onset · Retrograde P waves may appear just after QRS
✅ C) SVT — Supraventricular Tachycardia (AVNRT most common)

Narrow complex tachycardia at 150-250 bpm, abrupt onset/offset, P waves not visible (buried in QRS) or just after QRS (retrograde P, called "pseudo-r'" in V1 or "pseudo-S" in II). AVNRT: AV node re-entry — most common SVT. AVRT: Accessory pathway (WPW). Treatment: Stable → Vagal maneuvers first → Adenosine 6mg IV rapid push (flush fast!) → 12mg x2. Unstable → Synchronized cardioversion 50-100J. Rate 150 with P waves hidden → think SVT vs flutter. Key: adenosine will terminate SVT but only slow flutter temporarily (revealing flutter waves).

Q7 of 15 — What rhythm is shown?

📋 Key features: Rate 158/min · Regular · Wide QRS complexes (>120ms) · Monomorphic wide complex tachycardia · AV dissociation (independent P waves "marching through") · Fusion and capture beats
✅ B) Ventricular Tachycardia (VT)

Wide complex tachycardia = VT until proven otherwise! Criteria for VT: (1) AV dissociation (P waves independent of QRS — most specific finding), (2) Fusion beats (partial capture), (3) Capture beats, (4) QRS >140ms, (5) Extreme axis deviation (northwest axis). Brugada Criteria: If no RS complex in any V lead → VT. Management: Pulseless VT → ACLS cardiac arrest (defibrillate). VT with pulse, unstable → Synchronized cardioversion 100J. Stable → Amiodarone 150mg IV over 10 min, Lidocaine 1-1.5mg/kg. Never give adenosine to wide complex tachycardia unless certain it's SVT!

Q8 of 15 — What rhythm is shown? (Patient is unresponsive, no pulse)

📋 Key features: Chaotic disorganized waveform · No identifiable P waves, QRS, or T waves · Irregular amplitude and frequency · Rapid undulations · No organized electrical activity
✅ B) Ventricular Fibrillation (VF)

VF = chaotic disorganized electrical activity, no effective cardiac output, IMMEDIATELY FATAL without treatment. Immediate action: SHOCK FIRST (200J biphasic), then CPR 2 min, then recheck rhythm. While CPR ongoing: Epinephrine 1mg IV q3-5min, Amiodarone 300mg (or Lidocaine 1-1.5mg/kg) for refractory VF. Differentiating from artifact: VF has consistent chaos even when you move leads; patient is unresponsive; no pulse. Torsades: twisting QRS axis you can see morphology changing. Fine VF can look like asystole — treat as VF if any doubt.

Q9 of 15 — What rhythm is shown?

PR interval = 260ms (>200ms = prolonged)
📋 Key features: Rate 65/min · Regular · P wave before every QRS · Every P is followed by QRS · PR interval consistently prolonged at 260ms · Narrow QRS
✅ B) First-degree AV Block

Prolonged PR interval >200ms (0.20 seconds = 5 small boxes) + every P followed by QRS = 1st degree AV block. NOT a true "block" — conduction is just slowed (usually at AV node). All beats still conduct; just delayed. Causes: Increased vagal tone (athletes), inferior MI (RCA → AV node blood supply), medications (β-blockers, CCBs, digoxin, amiodarone), electrolyte disturbances. Management: Usually benign, no treatment needed. Monitor. Stop/adjust offending medications if symptomatic or PR very prolonged. Does not require pacing.

Q10 of 15 — What rhythm is shown?

P (no QRS)
📋 Key features: Progressive PR lengthening → dropped QRS → cycle resets · "Group beating" pattern · Narrow QRS in conducted beats · P-P interval constant · R-R intervals get shorter then suddenly lengthen after the dropped beat
✅ B) Mobitz Type I (Wenckebach) — 2nd Degree AV Block

Classic pattern: PR gets LONGER and LONGER until one P wave doesn't conduct (no QRS) → cycle resets with short PR. "Longer, longer, longer, drop — then you have a Wenckebach!" R-R intervals SHORTEN leading up to the dropped beat (despite PR lengthening). Location: AV node (benign). Causes: Inferior MI, increased vagal tone, medications, myocarditis. Management: Usually benign — monitor. If symptomatic → Atropine. Rarely needs pacing (compare to Mobitz II which is more dangerous and DOES need pacing). Key differentiator from Mobitz II: In Wenckebach, PR progressively lengthens. In Mobitz II, PR is CONSTANT then sudden drop.

Q11 of 15 — What rhythm is shown?

P→ no QRS
📋 Key features: Constant PR interval in conducted beats · Sudden dropped QRS with no warning · P wave not followed by QRS (without prior PR prolongation) · Wide QRS complexes in conducted beats · Unpredictable
✅ B) Mobitz II — 2nd Degree AV Block

Classic pattern: CONSTANT PR interval → sudden unexpected dropped QRS. No progressive PR prolongation. Location: Below AV node (His bundle or bundle branches) → more dangerous. Wide QRS in conducted beats. This is dangerous — can progress suddenly to complete (3rd degree) AV block or asystole without warning. Causes: Anterior MI (septal infarct destroys bundle branches), Lyme disease, myocarditis, infiltrative disease. Management: PACEMAKER indicated (transvenous/permanent). Atropine often ineffective (infranodal block). Transcutaneous pacing as bridge. Never rely on atropine alone for Mobitz II. MemoryAid: Mobitz I = AV node (node is friendly, Wenckebach is benign). Mobitz II = Below AV node (more serious = pacemaker).

Q12 of 15 — What rhythm is shown?

P waves (gray) march independent of QRS complexes
📋 Key features: P waves and QRS complexes completely INDEPENDENT of each other · Regular P-P interval (~rate 80) · Regular R-R interval (~rate 35, slow) · No consistent PR relationship · Wide, slow QRS (ventricular escape)
✅ B) Third-degree (Complete) AV Block

Complete AV dissociation: No impulses conduct from atria to ventricles. P waves "march through" QRS complexes at their own regular rate. Ventricles maintain escape rhythm: junctional escape (narrow QRS, rate 40-60) or ventricular escape (wide QRS, rate 20-40). This is a medical emergency! Patient is usually symptomatic: syncope, hemodynamic compromise, bradycardia. Causes: Inferior MI (right coronary artery → AV node), Lyme disease, medication toxicity (β-blockers, digoxin), congenital, degenerative disease (Lev's/Lenègre). Management: Transcutaneous pacing IMMEDIATELY → Transvenous pacing → Permanent pacemaker. Atropine only if narrow escape rhythm (junctional). IV epinephrine or dopamine as bridge.

Q13 of 15 — What is this bundle branch block?

V5-V6 lead: Broad notched R wave, no septal Q
📋 Key features: Wide QRS >120ms · Broad notched "M-shaped" R wave in leads I, aVL, V5-V6 · No septal Q waves in I or V5-V6 · rS pattern in V1-V2 · ST and T waves are discordant (opposite direction to QRS) in V5-V6
✅ B) Left Bundle Branch Block (LBBB)

LBBB Criteria: (1) QRS ≥120ms, (2) Broad notched or slurred R in I, aVL, V5-V6 ("M" or notched pattern), (3) rS or QS in V1-V3, (4) No septal Q waves in I, V5-V6, (5) ST/T discordance. Clinical importance: New LBBB + chest pain = STEMI equivalent → activate cath lab (Sgarbossa criteria help if needed). Causes: Hypertension (most common), CAD, cardiomyopathy, aortic stenosis. LBBB invalidates ST-segment interpretation for ischemia (everything is distorted). Memory trick: WiLLiaM MaRRoW → W pattern in V1 = LBBB; M pattern in V1 = RBBB... wait that's reversed. Try: "LBBB: lateral leads (I, V5-V6) show broad R; V1 shows rS" = turn it Left → "WiLL" → W in V1, M in lateral.

Q14 of 15 — What is this bundle branch block?

V1 lead: RSR' "rabbit ears" (M pattern)
📋 Key features: Wide QRS >120ms · RSR' pattern ("rabbit ears" or "M" pattern) in V1-V2 · Wide, slurred S wave in leads I, V5-V6 · Normal septal Q waves may be present · T wave discordance in V1-V2
✅ B) Right Bundle Branch Block (RBBB)

RBBB Criteria: (1) QRS ≥120ms, (2) RSR' ("rabbit ears" or "M" shape) in V1 or V2, (3) Wide/slurred S in I, V5-V6, (4) T wave inversion in V1-V3. RBBB is often incidental and benign. Causes: Normal variant, PE (acute cor pulmonale), ASD, anterior MI (septal branch), Brugada syndrome. Memory trick: MaRRoW → M in V1 = RBBB; W in V1 = LBBB. Or: R has right angles and RSR' looks like R pattern in V1. New RBBB + anterior MI = proximal LAD occlusion (bifascicular block). Brugada pattern: RBBB + ST elevation in V1-V3 = risk of sudden cardiac death → ICD.

Q15 of 15 — What is shown on this EKG?

Short PR + Delta wave (slurred QRS upstroke)
📋 Key features: Short PR interval <120ms · Delta wave (slurred upstroke of QRS) · Wide QRS >120ms (pseudo-wide) · These features cause secondary ST/T changes · Patient may have paroxysmal SVT or wide complex AFib
✅ C) Wolff-Parkinson-White (WPW) — Ventricular Pre-excitation

WPW Triad: (1) Short PR <120ms (bypasses AV node delay), (2) Delta wave (slurred QRS upstroke from early ventricular activation), (3) Wide QRS. Mechanism: Accessory pathway (Bundle of Kent) allows impulses to bypass AV node and pre-excite the ventricle. Risk: If AFib develops + WPW → rapid conduction down accessory pathway → VF and sudden cardiac death! AVOID AV-nodal blockers in WPW + AFib: adenosine, verapamil, diltiazem, β-blockers (can increase conduction through accessory pathway → VF). Treatment of WPW + AFib: Procainamide IV or cardioversion. Definitive: Radiofrequency catheter ablation of accessory pathway (curative).
ACLS — Advanced Cardiovascular Life Support Algorithms
VF / Pulseless VT — SHOCKABLE RHYTHM
1. Start High-Quality CPR immediately
Push hard (≥2 inches adult), push fast (100–120/min), allow full recoil, minimize interruptions (<10 sec), no hyperventilation (10 breaths/min), 30:2 ratio if 1 rescuer
2. Attach defibrillator — confirm VF/pVT
Deliver SHOCK: Biphasic 200J (or device-specific energy), Monophasic 360J
Resume CPR IMMEDIATELY after shock — do not check pulse first
3. CPR × 2 minutes + establish IV/IO access
💊 Epinephrine 1mg IV/IO — give as soon as IV/IO established, repeat every 3–5 min
No evidence for routine bicarb, calcium, or atropine in VF/VT
Rhythm check: Still shockable?
✅ YES → Shock again (same energy or escalating) → CPR × 2 min → Continue cycles
❌ NO → PEA/Asystole → See non-shockable algorithm
OR ROSC → Post-arrest care
↓ (if still shockable after 2nd shock)
💊 Amiodarone 300mg IV/IO (first dose) — for refractory VF/pVT
Second dose: 150mg if VF/VT persists
Alternative: Lidocaine 1–1.5mg/kg IV (then 0.5–0.75mg/kg q5-10min, max 3mg/kg)
Amiodarone or Lidocaine — either can be used (no proven mortality difference)
Consider and treat reversible causes (H's & T's) throughout
⭐ HIGH-YIELD ACLS PEARLS:
• CPR quality is the #1 determinant of survival
• Minimize interruptions — hands off <10 seconds for rhythm checks and shocks
• Push hard enough to depress sternum 2–2.4 inches (5–6 cm)
• Epinephrine improves ROSC rates but not neurological survival
• Drug delivery: Push IV bolus, then 20mL flush, elevate arm 10–20 seconds
• After ROSC: 12-lead EKG, targeted temperature management, consider PCI
PEA / Asystole — NON-SHOCKABLE RHYTHM
⚠️ Asystole: Confirm in 2 leads. Check connections. Treat as non-shockable.
PEA (Pulseless Electrical Activity): Organized electrical activity but NO palpable pulse. Always has an underlying cause.
1. Start High-Quality CPR immediately
💊 Epinephrine 1mg IV/IO — as soon as possible, ASAP! Repeat every 3–5 min
(Earlier epinephrine in non-shockable rhythms → improved ROSC rates)
2. CPR × 2 minutes — establish IV/IO, advanced airway if trained
Rhythm check: Shockable?
✅ YES → Switch to shockable algorithm (VF/VT) → Shock
❌ NO (still PEA/asystole) → Continue CPR cycles with Epi q3-5min
THROUGHOUT: Identify and treat reversible causes (H's & T's)
Consider specific antidotes:
• Suspected hyperkalemia: Calcium chloride 1g or calcium gluconate 3g IV
• Severe acidosis/TCA overdose: Sodium bicarbonate 1 mEq/kg IV
• Suspected PE: Consider thrombolytics (tPA 50mg IV) — CPR 60–90 min after
• Tamponade: Pericardiocentesis
• Tension pneumo: Needle decompression 2nd ICS MCL or 4th/5th ICS AAL
⭐ PEA vs Pseudo-PEA: True PEA = no cardiac activity on echo. Pseudo-PEA = some cardiac activity but insufficient output (may respond to aggressive treatment). Bedside echo during CPR pulse check is valuable — can identify tamponade, severe hypovolemia, massive PE.
Bradycardia — HR <60 bpm
Is the patient symptomatic?
(Hypotension, AMS, chest pain, signs of shock, acute HF)
NO — Asymptomatic
Observe and monitor
Search for underlying cause
Consider medication review
YES — Symptomatic
↓ Treat IMMEDIATELY
↓ (symptomatic)
💊 Step 1: Atropine 0.5mg IV — repeat every 3–5 min, max 3mg total
First-line for most symptomatic bradycardias
⚠️ Atropine NOT effective for Mobitz II or 3rd degree block (infranodal) — go straight to pacing!
↓ (if atropine insufficient)
Step 2: Transcutaneous Pacing (TCP)
• Set rate 60–80 bpm
• Increase mA until electrical capture (QRS after each pacing spike)
• Verify mechanical capture (palpate pulse at femoral or use pleth)
• Sedate patient if conscious (TCP is painful)
Alternative: Dopamine infusion 2–20 mcg/kg/min IV
Or: Epinephrine infusion 2–10 mcg/min IV
(Use as bridge if TCP unavailable or while preparing transvenous pacing)
↓ (if TCP fails or for definitive treatment)
Step 3: Transvenous Pacing (TVP) — cardiology consult, consider permanent pacemaker for: complete heart block, Mobitz II, symptomatic bradycardia unresponsive to medications
Causes of Bradycardia: β-blockers/CCBs/digoxin toxicity → calcium + glucagon (BBs), digoxin-specific Fab antibodies (digoxin). Inferior MI → RCA → AV node ischemia (atropine often works). Increased ICP (Cushing's triad: HTN + bradycardia + irregular respirations). Hypothyroidism. Hypothermia. Lyme disease.
Tachycardia — HR >100 bpm WITH Pulse
Hemodynamically UNSTABLE?
(Hypotension, AMS, severe CP, acute pulmonary edema, shock)
YES — UNSTABLE
→ Synchronized Cardioversion
AFib/Flutter: 120–200J biphasic
SVT/Monomorphic VT: 100J
Narrow regular: 50–100J
Sedate if conscious first
⚠️ Irregular WCT (afib+WPW): defibrillate (unsynchronized)
NO — STABLE
↓ Medical management based on QRS width
↓ (stable)
QRS Narrow (<120ms) or Wide (≥120ms)?
NARROW COMPLEX (<120ms)
Regular? → Vagal maneuvers → Adenosine 6mg IV rapid push + 20mL flush → 12mg (can repeat once) → β-blocker or diltiazem

Irregular? → AFib: rate control (diltiazem, β-blockers), anticoagulation, consider cardioversion. Flutter: rate control or cardioversion.
WIDE COMPLEX (≥120ms)
Regular? → Probable VT: Amiodarone 150mg over 10 min → Lidocaine → procainamide. If SVT with aberrancy suspected: adenosine (only if regular, monomorphic)

Irregular? → AFib+WPW: Procainamide or cardioversion (NO adenosine/digoxin/CCBs/BBs). Torsades: Magnesium 2g IV, correct QT-prolonging agents.
⭐ ADENOSINE RULES: 6mg IV rapid push directly into antecubital vein + immediate 20mL NS flush + elevate arm. Half-life = 10 SECONDS. Works on AV node (terminates SVT, slows AFib/flutter briefly to reveal flutter waves). NEVER use in WPW+AFib (can cause VF). CAUTION in severe asthma (bronchoconstriction).
Return of Spontaneous Circulation (ROSC)
Immediate goals (first 1–2 hours):
🫁 Airway/Breathing
• Verify ETT/advanced airway placement
• Maintain SpO₂ 92–98% (avoid hyperoxia)
• ETCO₂ 35–45 mmHg (avoid hyperventilation)
• 10 breaths/min with advanced airway
🩸 Hemodynamics
• Target SBP ≥90 mmHg
• MAP ≥65–70 mmHg
• IV fluids for hypotension
• Vasopressors: Norepinephrine or Dopamine
❤️ 12-Lead EKG
• Immediately after ROSC
• STEMI or new LBBB? → Emergent PCI
• Consider PCI even without ST elevation if cardiac cause suspected
🧠 Targeted Temperature Management (TTM)
• For comatose survivors
• Target core temp 32–36°C × 24h
• Prevent fever (≥38°C) for 72h post-arrest
💊 Post-ROSC Medications:
Vasopressors for shock: Norepinephrine 0.1–0.2 mcg/kg/min IV. If bradycardia: Dopamine 5–10 mcg/kg/min or Epinephrine 0.1–0.5 mcg/kg/min. Continue amiodarone infusion (1mg/min × 6h, then 0.5mg/min × 18h) if given during arrest for VF/VT.
5 H's & 5 T's to identify after ROSC: Look for correctable causes: Labs (K+, glucose, lactate, troponin, CBC), CXR, 12-lead EKG, POCUS (echo, lung), CT head if neurological cause suspected.
Reversible Causes of Cardiac Arrest — H's & T's

5 H's

CauseClue/Fix
HypoxiaLow SpO₂, cyanosis → 100% O₂, intubate
HypovolemiaHemorrhage, dehydration, PE → IV fluids, blood products, stop bleeding
H+ (Acidosis)ABG pH <7.1, DKA, sepsis, shock → NaHCO₃, treat cause
Hypo/HyperkalemiaK+ abnormalities, CKD, TLS → Calcium, insulin+glucose, kayexalate; or potassium replacement
HypothermiaCold exposure, temp <30°C → Active rewarming; continue CPR until warm ("not dead until warm and dead")

5 T's

CauseClue/Fix
Tension PneumothoraxAbsent breath sounds, tracheal deviation, hypotension → Needle decompression 2nd ICS MCL, then chest tube
Tamponade (cardiac)Beck's triad (JVD + muffled HS + hypotension), pulsus paradoxus, echo → Pericardiocentesis
Toxins (Overdose)Known OD, drug paraphernalia, pinpoint pupils → Naloxone (opioids), flumazenil (benzos, rarely), physostigmine (anticholinergics), atropine (organophosphates)
Thrombosis — CoronarySTEMI, ST changes → Emergent PCI, thrombolytics if PCI unavailable
Thrombosis — Pulmonary (PE)Risk factors, RBBB, S1Q3T3, low ETCO₂ → Consider tPA 50mg IV, consider ECMO, surgical embolectomy
⭐ Memory trick: H's = things you put IN the body (oxygen, fluids, bicarb, potassium, warmth). T's = things you take OUT or undo (needle for pneumo, needle for tamponade, antidote for toxin, cath for thrombosis).
ACLS Drug Quick Reference
DrugIndicationDoseNotes
EpinephrineCardiac arrest (any rhythm)1mg IV/IO q3–5minVasopressor — ↑aortic diastolic pressure → coronary perfusion during CPR
AmiodaroneRefractory VF/pVT; VT300mg IV/IO (arrest); 150mg over 10 min (stable)2nd dose 150mg. Infusion after ROSC: 1mg/min × 6h → 0.5mg/min × 18h
LidocaineRefractory VF/pVT (alternative)1–1.5mg/kg IV (arrest); 1–1.5mg/kg then 0.5–0.75mg/kg q5-10min (stable)Max 3mg/kg. Maintenance: 1–4mg/min infusion. Toxicity: seizures
AdenosineSVT (narrow regular)6mg rapid IV push → 12mg → 12mgHalf-life 10 sec. Must give rapid push + 20mL flush. CI: WPW+AFib
AtropineSymptomatic bradycardia0.5mg IV q3–5min, max 3mgIneffective for Mobitz II, 3rd degree (infranodal). Ineffective in transplanted heart.
MagnesiumTorsades de Pointes2g IV over 10 min (emergent); 1–2g over 5–60 min (stable)Also for severe hypomagnesemia, eclampsia seizures
DopamineBradycardia (bridge), cardiogenic shock2–20 mcg/kg/min IV2–5: renal; 5–10: cardiac (↑HR, CO); >10: vasopressor
NorepinephrinePost-arrest shock, septic shock0.1–0.2 mcg/kg/min IV titrateFirst-line vasopressor post-ROSC and septic shock
Calcium ChlorideHyperkalemia, CCB OD1g IV (CaCl) or 3g calcium gluconateCaCl has 3× more elemental calcium. Stabilizes cardiac membrane.
Sodium BicarbonateSevere acidosis, hyperkalemia, TCA OD1 mEq/kg IVFor prolonged arrest. Routine use not recommended in VF/VT.
ProcainamideStable VT, WPW+AFib20–50mg/min IV until arrhythmia suppressed (max 17mg/kg); stop if QRS widens >50% or hypotensionDrug of choice for WPW+AFib (blocks accessory pathway)
PALS — Pediatric Advanced Life Support
Pediatric Cardiac Arrest — Pulseless
Key differences from Adult ACLS:
• CPR ratio: 30:2 (1 rescuer), 15:2 (2 rescuers, in-hospital/BLS)
• Compression depth: ≥1/3 AP diameter (~1.5 inches infants, ~2 inches children)
• Rate: 100–120/min (same as adults)
• Defibrillation: 2 J/kg first shock → 4 J/kg → 4 J/kg (or higher) — max 10 J/kg or adult dose
Shockable rhythm? (VF / pVT)
SHOCKABLE (VF/pVT)
1. CPR immediately
2. Shock: 2 J/kg (first), 4 J/kg (subsequent)
3. Resume CPR × 2 min
4. Epinephrine 0.01 mg/kg IV/IO (after 2nd shock, then q3–5min)
5. Amiodarone 5 mg/kg IV/IO (max 300mg) after 3rd shock
OR Lidocaine 1 mg/kg IV/IO
6. Treat H's & T's
NON-SHOCKABLE (Asystole/PEA)
Most common peds arrest = ASPHYXIAL → fix hypoxia first!
1. CPR immediately
2. Epinephrine 0.01 mg/kg IV/IO q3–5min (ASAP)
3. Optimize airway/ventilation (100% O₂)
4. Treat H's & T's (hypoxia #1 cause)
5. Consider IO access if no IV within 60 sec
⭐ Key PALS Concepts:
• Pediatric cardiac arrest is almost always SECONDARY to respiratory failure or shock (vs adults where primary cardiac is more common)
• Fix the airway first! Most pediatric arrests are hypoxic in origin
• IO access (tibial or humeral) if IV not obtained within 60 seconds
• Vasovagal rarely causes pediatric arrest; consider structural heart disease (HCM, congenital anomalies)
• Hypoglycemia is common during pediatric arrest — check glucose!
Pediatric Bradycardia (HR <60 with poor perfusion)
⚠️ Key PALS Rule: HR <60 WITH signs of poor perfusion (AMS, cyanosis, hypotension) despite adequate oxygenation/ventilation → START CPR! Unlike adults, the threshold to start CPR for bradycardia is lower in infants and children because they are more heart rate–dependent for cardiac output.
1. First — optimize oxygenation and ventilation!
• Apply 100% O₂ via NRB or BVM
• Ensure airway open; suction secretions
• Many pediatric bradycardias are hypoxic in origin — this alone may resolve the bradycardia
Still bradycardic with poor perfusion despite O₂?
↓ YES
💊 Epinephrine 0.01 mg/kg IV/IO (max 1mg) — repeat q3–5min
💊 Atropine 0.02 mg/kg IV/IO (min 0.1mg, max 0.5mg per dose, max 1mg total) — for increased vagal tone or primary AV block
May repeat atropine once
If no response → Cardiac Pacing: Transcutaneous pacing (painful, sedate if possible). Transvenous pacing if TCP ineffective. Consider pacing if complete heart block, Lyme carditis, congenital heart disease.
Common causes pediatric bradycardia: Hypoxia (#1), vagal stimulation (suctioning, intubation, defecation), complete heart block (congenital, maternal lupus anti-Ro/La antibodies, post-surgical), increased ICP, medications (β-blockers, digoxin), hypothyroidism, hypothermia, Lyme carditis.
Pediatric Tachycardia With Pulse
Hemodynamically UNSTABLE?
(Altered LOC, severe respiratory distress, poor perfusion)
UNSTABLE → Synchronized Cardioversion
0.5–1 J/kg (first attempt)
2 J/kg (subsequent attempts)
Sedate/analgesia if possible
If unable to sync or Torsades → defibrillate (unsynchronized)
STABLE → Identify rhythm
Narrow (<0.09 sec) vs Wide (≥0.09 sec)
↓ (stable, narrow complex)
SVT (most common narrow complex tachycardia in children):
• Infants: HR typically 220–300 bpm (often mistaken for sinus tachy!)
• Children: HR typically 180–240 bpm
• Abrupt onset/offset, no P waves or retrograde P waves
• Sinus tach usually <220 infants, <180 older children, has gradual rate variation
SVT Management (stable):
1. Vagal maneuvers — ice bag to face (diving reflex) for infants; Valsalva for older children
2. Adenosine 0.1 mg/kg IV rapid push (max first dose 6mg, max second dose 12mg) + 5–10mL NS flush
3. If adenosine fails or refractory: Amiodarone 5 mg/kg over 20–60 min; OR Procainamide 15 mg/kg over 30–60 min
Wide Complex Tachycardia (VT in children):
• Less common than in adults
• Causes: Prolonged QT, congenital heart disease, channelopathies, electrolyte abnormalities, myocarditis
• Treat as VT: Amiodarone 5 mg/kg IV over 20–60 min OR Procainamide 15 mg/kg IV over 30–60 min
• Torsades: Magnesium 25–50 mg/kg IV (max 2g)
Pediatric Shock Recognition & Management
Shock in children: Compensated shock (tachycardia + poor perfusion, but normal BP — children COMPENSATE well until decompensation) vs Hypotensive shock (decompensated = urgent). Normal pediatric BP: Systolic ≥70 + (2 × age in years) mmHg
TypeMechanismSignsTreatment
Hypovolemic↓Blood volume (hemorrhage, dehydration, burns)Tachycardia, dry mucous membranes, sunken fontanelle, flat JVP, weak pulsesIV/IO 20 mL/kg NS or LR bolus, repeat PRN; blood products for hemorrhagic shock; stop bleeding
Distributive (Septic)Vasodilation, maldistribution (warm shock) or vasoconstriction (cold shock)Warm: warm extremities, bounding pulses, wide pulse pressure. Cold: mottled, cool extremities, weak pulses20 mL/kg NS bolus (up to 60 mL/kg in 1st hour if no HF); antibiotics; vasopressors if refractory to fluids
Cardiogenic↓CO (myocarditis, congenital HD, post-surgical)Hepatomegaly, pulmonary edema, JVD, S3, poor perfusionCareful fluid (5–10 mL/kg bolus), inotropes (dobutamine, milrinone), avoid large volumes
ObstructiveTension pneumo, tamponade, ductal-dependent lesionSevere respiratory distress, JVD, muffled heart sounds, unequal breath soundsNeedle decompression (pneumo), pericardiocentesis (tamponade), PGE1 for ductal-dependent lesions (alprostadil)
Vasopressors in pediatric shock:
Cold shock (septic, low CO): Epinephrine 0.1–1 mcg/kg/min IV/IO (inotrope + vasopressor)
Warm shock (vasodilatory): Norepinephrine 0.1–2 mcg/kg/min IV/IO (vasoconstriction)
Cardiogenic shock: Dobutamine 5–20 mcg/kg/min (↑contractility) or Milrinone 0.25–0.75 mcg/kg/min (PDE inhibitor, ↑CO + vasodilate)
Septic shock empiric antibiotics: Broad spectrum: Vancomycin + Piperacillin-tazobactam (or cefepime) ± anti-fungal if immunocompromised
PALS Pediatric Drug Dose Reference
⚠️ Weight-based dosing: Always calculate based on actual body weight (or estimated weight if unavailable). Use Broselow tape for quick weight estimation. Maximum doses apply — do not exceed adult doses.
DrugIndicationDoseMaxNotes
EpinephrineCardiac arrest, anaphylaxis, bradycardia0.01 mg/kg IV/IO
1:10,000 solution = 0.1 mL/kg
1mgq3–5min in arrest. Anaphylaxis: IM 0.01mg/kg (1:1000)
AtropineSymptomatic bradycardia, vagal, RSI pretreatment0.02 mg/kg IV/IO0.5mg/dose; 1mg totalMinimum dose 0.1mg (paradoxical bradycardia with lower doses)
AdenosineSVT0.1 mg/kg IV rapid push6mg (1st), 12mg (2nd)Must give rapid IV push + flush immediately
AmiodaroneVF/pVT (arrest), VT, SVT refractory5 mg/kg IV/IO (arrest: rapid; stable: over 20–60 min)300mgCan repeat to max 15 mg/kg/day
LidocaineVF/pVT (arrest alternative), VT1 mg/kg IV/IO3mg/kg maxInfusion: 20–50 mcg/kg/min. Monitor for toxicity.
MagnesiumTorsades de Pointes, hypomagnesemia25–50 mg/kg IV2gFor torsades: rapid push. Slow infusion 15–30 min for stable.
GlucoseHypoglycemia0.5–1 g/kg IV
Neonates: D10W 2–4 mL/kg
Infants/children: D25W 2–4 mL/kg
Adolescents: D50W 1 mL/kg
Check BG frequently. Recheck after treatment.
Sodium BicarbonateSevere acidosis, hyperkalemia, TCA OD1 mEq/kg IV slow pushDo not mix with calcium. May worsen cellular acidosis if given too rapidly.
Calcium GluconateHyperkalemia, CCB OD, hypocalcemia60–100 mg/kg IV (= 0.6–1 mL/kg of 10% solution)3g (calcium gluconate)Give slowly (over 5–10 min) — rapid administration causes bradycardia
NaloxoneOpioid OD/reversal0.01 mg/kg IV/IO/IM2mgMay need repeat dosing or infusion (shorter T½ than most opioids)
Prostaglandin E1 (alprostadil)Ductal-dependent congenital heart lesions0.05–0.1 mcg/kg/min IVKeeps PDA open. SE: Apnea (have intubation ready!), fever, hypotension
Pediatric Normal Vital Signs Reference
AgeHR (awake)RRSystolic BPWeight (avg)
Neonate (0–1mo)100–16030–6060–90~3.5 kg
Infant (1–12mo)100–16025–5070–100~4–10 kg
Toddler (1–3yr)90–15020–3080–110~10–15 kg
Preschool (3–5yr)80–14018–2580–115~15–20 kg
School age (6–12yr)70–12014–2290–120~20–40 kg
Adolescent (12–18yr)60–10012–18100–140~40–70 kg
Minimum Systolic BP Formula: ≥70 + (2 × age in years) mmHg for children >1 year old. Below this = hypotensive shock. Broselow Tape: Measures child's length to estimate weight and provide color-coded drug doses — use in ALL pediatric codes.
Valvular Heart Disease
Murmur Mnemonics: PASS = Pulmonic & Aortic Stenosis = Systolic  |  PAID = Pulmonic & Aortic Insufficiency = Diastolic  |  Mitral/Tricuspid: Stenosis = Diastolic, Regurgitation = Systolic
Valve LesionMurmurBest HeardRadiationKey FeaturesTreatment
Aortic StenosisCrescendo-decrescendo systolic ejectionRUSB (2nd ICS R)CarotidsSAD: Syncope, Angina, Dyspnea. Pulsus parvus et tardus. S4. LVH. Calcified on echo. Most common valve disease in elderly. AVA <1cm2 = severe.AVR or TAVR when symptomatic. AVOID vasodilators (fixed obstruction = dangerous hypotension).
Aortic RegurgitationBlowing diastolic decrescendoLUSB; lean forward, breathe outNone specificWide pulse pressure. Water-hammer (Corrigan) pulse. Hill sign. Austin Flint murmur (mid-diastolic at apex, not MS). Quincke pulse. Musset sign (head bobbing).Chronic: ACEi/ARB. Severe or EF<55% → AVR. Acute AR (endocarditis/dissection) = emergency surgery.
Mitral StenosisLow-pitched diastolic rumbleApex; bell, left lateral decubitusNoneOpening snap after S2. Shorter S2-OS = more severe. AFib common (LA dilation). Rheumatic fever etiology.Rate control, anticoagulate for AFib. Balloon valvuloplasty if pliable, no MR, no LA thrombus. MVR otherwise.
Mitral RegurgitationHolosystolic blowingApexAxillaSoft S1. S3. Laterally displaced PMI. LA/LV dilation. Acute MR (papillary rupture post-MI or chordae) = flash pulmonary edema, emergency OR.ACEi, diuretics. Repair/replace when EF<60%, LVESD>40mm, or symptomatic.
Mitral Valve ProlapseMid-systolic click ± late systolic murmurApexNoneMost common valvular abnormality. Young women. Click moves EARLIER with ↓ preload (standing, Valsalva) and LATER with ↑ preload (squatting).Usually benign. BB for palpitations. Surgical repair if severe MR.
Tricuspid RegurgitationHolosystolic systolicLLSB (4th ICS)NoneIncreases with INSPIRATION (Carvallo sign). JVD with CV waves. Pulsatile hepatomegaly. IVDU → TR + S. aureus endocarditis.Treat underlying cause. Diuretics. Surgical repair with left-sided surgery.
Pulmonic StenosisCrescendo-decrescendo systolicLUSB (2nd ICS L)Left shoulderWide split S2. Ejection click decreases with inspiration (unique to PS). Congenital (Noonan syndrome). RVH.Balloon valvuloplasty if gradient >40mmHg or symptomatic.
Murmur Maneuvers
ManeuverEffectHOCMMVP (click timing)Most other murmurs
Valsalva / Standing↓ PreloadLOUDERClick moves EARLIERMost softer
Squatting / Hand Grip↑ Preload / ↑ AfterloadSofterClick moves LATERMost louder (MR, AR louder; AS softer with hand grip)
Inspiration↑ Right heart fillingNo changeNo changeRight-sided murmurs LOUDER (TR, PS, TS) — Carvallo sign
HOCM vs MVP: Both get worse with ↓ preload and better with ↑ preload — opposite of most valvular murmurs. "Empty heart = bad for both." HOCM heard at LSB/apex. AS heard at RUSB.
Matching — Valve Lesion Identification

Match each clinical finding (left) to the correct valve lesion (right):

Crescendo-decrescendo systolic murmur at RUSB radiating to carotids; syncope; pulsus parvus et tardus
Mitral Regurgitation
Opening snap + low-pitched diastolic rumble at apex; history of rheumatic fever; AFib
Aortic Stenosis
Holosystolic blowing murmur at apex radiating to axilla; S3; laterally displaced hyperdynamic PMI
Mitral Valve Prolapse
Blowing diastolic decrescendo murmur at LSB; wide pulse pressure; water-hammer pulse; Austin Flint murmur
Mitral Stenosis
Mid-systolic click that moves earlier with Valsalva and later with squatting; young woman
Aortic Regurgitation
UWorld/PANCE-Style Questions — Valvular Disease

Q1 — Aortic Stenosis Management

A 72-year-old man has a harsh crescendo-decrescendo systolic murmur at the RUSB radiating to the neck, exertional syncope, and an echocardiogram showing AVA 0.8 cm². What is the most appropriate next step?
B) Aortic Valve Replacement (AVR) — Severe symptomatic AS (SAD: Syncope, Angina, Dyspnea). AVA <1cm² = severe. Once symptomatic: syncope → 3yr survival, HF → 1-2yr survival without AVR. TAVR if high surgical risk. AVOID vasodilators (fixed obstruction → dangerous hypotension). BBs can also precipitate acute decompensation. Definitive treatment = valve replacement.

Q2 — Mitral Valve Prolapse Maneuvers

A 26-year-old woman has a mid-systolic click at the apex. When she squats, the click moves later in systole. Which best explains this?
C) Squatting increases preload → leaflet prolapses LATER. MVP click timing = LV volume: ↑ Volume (squatting, supine) → LV full → better leaflet support → click moves toward S2 (later), murmur shorter. ↓ Volume (standing, Valsalva) → LV empty → earlier prolapse → click moves toward S1 (earlier), murmur longer/louder. Opposite of what you might expect. HOCM has same directional response as MVP (both worse with empty LV).

Q3 — Right-Sided Endocarditis

A 32-year-old IV drug user has 3 weeks of fever, a holosystolic murmur at the LLSB that increases with inspiration, JVD, and pulsatile hepatomegaly. Blood cultures grow S. aureus. Which valve is affected?
C) Tricuspid valve — S. aureus. IVDU → right-sided endocarditis → tricuspid valve. TR murmur = holosystolic at LLSB, increases with inspiration (Carvallo sign). JVD + pulsatile hepatomegaly = right heart signs. S. aureus = most virulent, most common in acute IE and IVDU. Classic complication: septic pulmonary emboli (bilateral cavitary infiltrates on CXR). Treatment: Oxacillin or vancomycin (if MRSA) x 6 weeks.

Q4 — Aortic Regurgitation Signs

A 50-year-old man has a diastolic decrescendo murmur at the LSB, BP 160/52, and a mid-diastolic rumble at the apex without mitral stenosis. Which peripheral sign is IMMUNE-MEDIATED (not embolic)?
C) Osler nodes = immune complex mediated. IE peripheral findings: Osler nodes = PAINFUL fingertip/toe nodules = immune complex (minor Duke criterion). Janeway = PAINLESS hemorrhagic lesions on palms/soles = septic emboli. Splinter hemorrhages = septic emboli. Roth spots = retinal with white center = immune complex. "Osler = Ouch = immune." The AR murmur here + Austin Flint murmur (AR jet vibrating anterior MV leaflet = mid-diastolic rumble) + wide pulse pressure = classic AR. AR causes wide pulse pressure (BP 160/52 = 108 PP).

Q5 — Mitral Stenosis Intervention

A 35-year-old woman with rheumatic mitral stenosis (MVA 1.1 cm², heavily calcified valve, no MR) develops worsening dyspnea and new AFib. What is the most appropriate intervention for her MS?
B) Mitral valve replacement. MVA <1.5cm² = severe MS requiring intervention. However, balloon valvuloplasty (PMBV) is CONTRAINDICATED when the valve is heavily calcified (won't open properly) or when significant MR is present. PMBV ideal: pliable valve, no calcification, no significant MR, no LA thrombus. Since PMBV not feasible → MVR. Also: AFib in MS → anticoagulate (DOAC or warfarin). Rate control with BB or diltiazem (avoid digoxin as monotherapy — doesn't adequately control rate with exertion).

Q6 — Murmur with Hand Grip

A 68-year-old man has a systolic ejection murmur at the RUSB that decreases with isometric hand grip exercise. Which condition does this most likely represent?
C) Aortic Stenosis. RUSB + systolic ejection murmur = AS. Hand grip → ↑ afterload → ↑ LV pressure → less gradient across fixed aortic valve obstruction → AS murmur SOFTER. Compare: MR = hand grip → ↑ afterload → more backflow → MR louder. HOCM = hand grip → ↑ preload/afterload → less outflow obstruction → HOCM softer (but heard at LSB/apex, not RUSB). RUSB + radiates to carotids + ejection quality + decreases with hand grip = classic AS.
Inflammatory, Infectious & Traumatic Heart Disease

🔥 Pericarditis

Causes: Viral #1 (Coxsackievirus B), autoimmune (SLE, RA), uremia, post-MI (Dressler syndrome 2-6 wks), TB, malignancy, post-cardiac surgery

Symptoms: Pleuritic chest pain relieved by leaning forward (tripod position), fever, friction rub (pathognomonic — leathery scratching)

EKG: Diffuse saddle-shaped (concave up) ST elevation in MULTIPLE leads + PR depression (opposite of STEMI which is focal, convex ST elevation)

Tx: NSAIDs (ibuprofen 600mg TID x2wk) + Colchicine 0.5mg BID x3mo (reduces recurrence). Avoid anticoagulation. Steroids only if refractory.

💜 Myocarditis

Causes: Viral (Coxsackievirus B #1, CMV, HIV, COVID-19), autoimmune, drugs (clozapine, checkpoint inhibitors), giant cell myocarditis

Symptoms: Young patient, recent viral URI prodrome (1-2 wks prior), chest pain, dyspnea, fatigue, palpitations, fever

Findings: ↑ Troponin, ↑ BNP, new dilated cardiomyopathy (EF↓), diffuse LV dysfunction. Cardiac MRI: late gadolinium enhancement (gold standard for diagnosis). ECG: diffuse ST changes or heart block.

Tx: Supportive (rest, avoid NSAIDs in first 3 months). GDMT for HFrEF if EF↓. ICD if EF stays <35%.

🦠 Infective Endocarditis

Organisms: S. viridans (subacute, dental, native valve), S. aureus (#1 acute; IVDU, prosthetic), Enterococcus (GI/GU procedures), HACEK (culture-negative), S. bovis/gallolyticus → COLONOSCOPY (colon cancer!)

Duke Criteria: 2 major OR 1 major + 3 minor OR 5 minor = definite IE
Major: (+) blood cx x2, echo vegetation/abscess/new regurg
Minor: fever, vascular phenomena, immunologic phenomena, predisposing heart disease, IVDU

Peripheral signs: Osler nodes (painful fingers/toes, immune), Janeway lesions (painless palms/soles, septic emboli), Roth spots (retinal hemorrhages), splinter hemorrhages, new murmur
ConditionClassic PresentationKey FindingsTreatment
Cardiac TamponadeHypotension, dyspnea, distant heart sounds. Often post-procedure, trauma, malignancy, or uremiaBeck Triad: JVD + Muffled heart sounds + Hypotension. Pulsus paradoxus (>10 mmHg drop in SBP with inspiration). EKG: low voltage + electrical alternans (QRS alternates height). Echo: RA/RV collapse, swinging heart.Pericardiocentesis (emergent). Avoid diuretics/vasodilators. Maintain HR and preload (IV fluids). Avoid intubation if possible (↓ preload kills these patients).
Aortic DissectionSudden, severe "tearing" or "ripping" chest/back pain in hypertensive patient. Pain often maximal at ONSET (vs MI which builds gradually)Unequal blood pressures in arms (>20mmHg difference). Widened mediastinum on CXR (>8cm or >50% chest width). Pulse deficit. AR murmur if Type A extends to aortic root. CT angiography = gold standard.Stanford A (ascending aorta) → EMERGENCY SURGERY. Stanford B (descending only) → Medical management: IV labetalol or esmolol (↓HR <60, ↓SBP <120). Nitroprusside for BP but ONLY after BB.
Rheumatic Heart Disease2-6 weeks after Group A Strep pharyngitis (Strep pyogenes). Children/young adults. Mitral stenosis most common late sequela.Jones Criteria: MAJOR: Carditis, Polyarthritis, Chorea (Sydenham), Erythema marginatum, Subcutaneous nodules. MINOR: Fever, ↑ESR/CRP, prolonged PR interval. Diagnosis: 2 major OR 1 major + 2 minor + evidence of preceding Strep infection (ASO titer, throat culture)Penicillin for Strep eradication. ASA/NSAIDs for arthritis. Steroids for severe carditis. Penicillin prophylaxis for years (prevents recurrence → prevents further valve damage).
Cardiac ContusionBlunt chest trauma (MVC steering wheel injury, fall from height). RV most vulnerable (anterior position)Most common dysrhythmia: sinus tachycardia, PVCs, afib, VT. EKG: new RBBB, ST changes, arrhythmias. Troponin elevated. Echo: wall motion abnormalities.Continuous cardiac monitoring x 24-48h. Treat arrhythmias. Anticoagulation controversial (bleeding risk). IABP or surgical repair if severe LV dysfunction.
Endocarditis Prophylaxis Indications (AHA): Prosthetic valves, previous IE, certain congenital heart defects (unrepaired cyanotic, repaired with residual defects), cardiac transplant with valvulopathy. Procedure: Dental procedures causing gingival manipulation. Drug: Amoxicillin 2g PO 30-60 min before. If PCN allergic: Clindamycin 600mg or azithromycin 500mg.
Matching — Cardiac Inflammatory/Infectious Diagnoses

Match the finding (left) to the correct diagnosis (right):

Beck triad (JVD, muffled heart sounds, hypotension) + pulsus paradoxus + electrical alternans on EKG
Pericarditis
Painful raised nodules on fingertips + painless hemorrhagic lesions on palms + new regurgitant murmur + fever
Cardiac Tamponade
Diffuse saddle-shaped ST elevation + PR depression + pleuritic chest pain relieved by sitting forward + pericardial friction rub
Aortic Dissection
Young patient, viral URI 2 weeks prior, dilated cardiomyopathy, elevated troponin, diffuse LV dysfunction
Infective Endocarditis
Sudden tearing chest pain radiating to back + unequal arm BP + widened mediastinum on CXR
Myocarditis
UWorld/PANCE-Style Questions — Inflammatory/Infectious Cardiac

Question 1 of 6

A 22-year-old man presents with sharp chest pain that is worse when lying flat and relieved by sitting forward. He had a flu-like illness 2 weeks ago. Temperature is 38.2°C. EKG shows diffuse ST elevation that is concave upward in multiple leads with PR depression. Troponin is mildly elevated. Echocardiography shows a small pericardial effusion but no cardiac tamponade. What is the most appropriate initial treatment?
✅ B) Ibuprofen + colchicine

This is acute pericarditis: pleuritic chest pain relieved sitting forward, friction rub, diffuse saddle-shaped ST elevation with PR depression, recent viral illness. First-line treatment is NSAID (ibuprofen 600mg TID x 2 weeks) + colchicine 0.5mg BID x 3 months — colchicine dramatically reduces recurrence rate (50% → 10%).

❌ Steroids: reserved for refractory/recurrent cases ONLY — steroids increase recurrence risk if given early. ❌ Pericardiocentesis: only if large effusion causing tamponade. The elevated troponin indicates some myopericarditis (inflammation of epicardium/myocardium) — restrict physical activity until CRP normalizes.

Question 2 of 6

A 45-year-old man with end-stage renal disease on hemodialysis presents with worsening dyspnea and hypotension. He missed his last two dialysis sessions. Exam: BP 82/60 mmHg, HR 118/min, JVP elevated, heart sounds distant and muffled. EKG shows low-voltage QRS complexes that alternate in height. Bedside ultrasound shows a large pericardial effusion with RV collapse during diastole. What is the next best step?
✅ C) Emergent pericardiocentesis

This is cardiac tamponade: Beck triad (hypotension + JVD + muffled heart sounds) + electrical alternans + RV diastolic collapse on echo = EMERGENCY. Tamponade = pericardial fluid compresses heart, preventing filling = obstructive shock.

Pericardiocentesis is the only definitive treatment. Remove fluid → immediately restores cardiac output. While preparing: IV fluids to maintain preload (NOT diuretics — furosemide would kill this patient by reducing preload). Avoid anything that drops heart rate or preload.

Cause here: uremic pericarditis (ESRD + missed dialysis = classic). Dialysis can be done after stabilization. Electrical alternans = QRS amplitude alternates due to heart "swinging" in large effusion — pathognomonic for tamponade.

Question 3 of 6

A 68-year-old man presents with 3 weeks of fever, fatigue, and weight loss. He had a dental cleaning 6 weeks ago and has a known bicuspid aortic valve. Exam reveals temperature 38.6°C, a new aortic regurgitation murmur, and painless erythematous lesions on both palms. Blood cultures (3 sets) grow Streptococcus viridans. Which of the following peripheral findings is IMMUNE COMPLEX-mediated (not septic emboli)?
✅ C) Osler nodes

Peripheral manifestations of IE:
Osler nodes = PAINFUL raised nodules on fingertips/toes = immune complex deposition (minor Duke criterion "immunologic phenomena")
Janeway lesions = PAINLESS flat hemorrhagic lesions on palms/soles = septic emboli (major Duke criterion "vascular phenomena")
Splinter hemorrhages = under nails, septic emboli
Roth spots = retinal hemorrhages with white centers, immune complex

Memory: "Osler = Ouch (painful) = Oh, immune complex. Janeway = J = Just painless emboli."

This is subacute IE: S. viridans (dental source), native valve (bicuspid AV), 3+ weeks course. Treatment: Penicillin G IV x 4-6 weeks (or ceftriaxone). Add gentamicin for synergy in first 2 weeks.

Question 4 of 6

A 52-year-old hypertensive man presents to the ED with sudden severe "ripping" chest pain that radiates to his back and started 30 minutes ago. BP is 188/96 in the right arm and 154/82 in the left arm. CXR shows a widened mediastinum. CT angiography reveals involvement of the ascending aorta. What is the most appropriate management?
✅ C) Emergency surgical repair

This is Type A aortic dissection (ascending aorta involved — Stanford A, DeBakey I or II) = surgical emergency. Untreated Type A mortality: 1-2% per hour. Risk of rupture into pericardium (tamponade), coronary ostia (MI), aortic root (AR), stroke.

❌ Medical management alone is for Type B (descending only, Stanford B) without complications. While preparing for OR: IV esmolol or labetalol (target HR <60, SBP 100-120). If BP still high after HR controlled → add nitroprusside (never nitroprusside alone — reflex tachycardia increases aortic shear stress). ❌ Heparin is CONTRAINDICATED — dissection can bleed into pericardium.

Question 5 of 6

A 14-year-old girl presents with migratory joint pain, fever, and a skin rash consisting of pale-centered, ring-shaped lesions on the trunk. She had a sore throat 3 weeks ago that was not treated. Auscultation reveals a new mitral regurgitation murmur. ASO titer is markedly elevated. Throat culture is negative now. Which of the following is the MOST specific major Jones criterion?
✅ D) Sydenham chorea

This is Acute Rheumatic Fever (ARF) following GAS pharyngitis. Jones Criteria Major: C-A-N-E-S = Carditis, Arthritis (migratory polyarthritis — most common), chorea (Sydenham), Erythema marginatum, Subcutaneous nodules.

Sydenham chorea is the most specific finding for ARF (it's rarely caused by anything else). It may appear weeks to months after the strep infection. Erythema marginatum (pale-centered ring-shaped rash on trunk) is also highly specific but less common than arthritis.

This patient has: arthritis + carditis (new MR murmur) + erythema marginatum + elevated ASO = 2 major criteria + evidence of Strep → DEFINITE ARF. Treatment: Penicillin (eradicate Strep) + ASA for arthritis + Penicillin prophylaxis monthly IM BZN for years.

Question 6 of 6

A 35-year-old man presents after a high-speed MVC where his chest struck the steering wheel. He complains of anterior chest pain. VS: BP 110/70, HR 102, RR 18, SpO2 97%. EKG shows a new RBBB and frequent PVCs. Troponin is 2.1 ng/mL (ULN 0.04). Echo shows anterior RV wall motion abnormality with preserved LV function. Which of the following is the most appropriate next step?
✅ B) Continuous cardiac monitoring for 24-48 hours

This is myocardial contusion (blunt cardiac trauma). Classic: MVC + steering wheel + elevated troponin + new arrhythmias (RBBB, PVCs) + RV wall motion abnormality (RV most anterior = most susceptible to blunt trauma).

Management: Continuous EKG monitoring x 24-48h for life-threatening arrhythmias (VT/VF). Treat arrhythmias as they arise. Hemodynamic monitoring. ❌ Anticoagulation: contraindicated (hemorrhagic myocardial contusion can worsen). ❌ Cardiac cath: no ischemia pattern (troponin elevation from contusion, not thrombosis). Most contusions are managed supportively with good outcomes.
Introduction to Trauma — Primary Survey, ATLS, & Life-Threatening Injuries
⭐ Golden Hour: Definitive hemorrhage control within 60 minutes of injury = best survival. Primary survey MUST be completed in <2 minutes. Treat each life threat as found — do NOT delay to complete survey.
Primary Survey — ABCDE
StepActionLife Threats FoundIntervention
A — Airway (with C-spine protection)Assess patency: stridor, gurgling, phonation, clenched teeth, blood/vomitAirway obstructionJaw thrust (not head tilt), suction, OPA/NPA, RSI + intubation, surgical airway (cricothyrotomy) if cannot intubate
B — BreathingInspect, auscultate, palpate chest. SpO₂. Respiratory rate.Tension pneumothorax, open pneumothorax, massive hemothorax, flail chestNeedle decompression (tension), occlusive dressing (open pneumo), chest tube, PPV/PEEP (flail)
C — CirculationPulse quality, skin color/temp, cap refill, external hemorrhage, BPHemorrhagic shock, cardiac tamponadeDirect pressure, tourniquet, 2 large-bore IVs, blood products (1:1:1 PRBC:FFP:Plt), pericardiocentesis
D — DisabilityGCS, pupils (size, reactivity, symmetry), lateralizing signsTBI, herniation, spinal cord injuryAvoidHypotension+Hypoxia, HOB 30°, hyperventilate if herniation (pCO₂ 35), neurosurgery consult
E — Exposure/EnvironmentFully undress patient, logroll (spine precautions), rectal tempHidden injuries, hypothermiaWarm blankets, warm fluids, warming lights. "Lethal triad": Hypothermia + Acidosis + Coagulopathy
Hemorrhagic Shock Classification
ClassBlood LossHRBPRRUO (mL/hr)Mental StatusTreatment
Class I<750 mL (<15%)<100Normal14-20>30AnxiousCrystalloid; may not need transfusion
Class II750-1500 mL (15-30%)100-120Normal20-3020-30Anxious/confusedCrystalloid ± blood
Class III1500-2000 mL (30-40%)120-14030-405-20Confused/lethargicBlood products (1:1:1); likely needs OR
Class IV>2000 mL (>40%)>140Very ↓>35NegligibleObtunded/unconsciousImmediate surgery; massive transfusion protocol
Memory: BP doesn't drop until Class III (>30% blood loss). Tachycardia is the first sign of hemorrhagic shock (Class I and II). Children and athletes may not show tachycardia until significant blood loss (excellent compensation). Elderly patients on β-blockers cannot mount tachycardic response.
Glasgow Coma Scale (GCS)

👁 Eyes (E)

4 = Spontaneous
3 = To voice
2 = To pain
1 = None

🗣 Verbal (V)

5 = Oriented
4 = Confused
3 = Words
2 = Sounds
1 = None

💪 Motor (M)

6 = Follows commands
5 = Localizes pain
4 = Withdraws
3 = Flexion (decorticate)
2 = Extension (decerebrate)
1 = None

📊 Interpretation

Max: 15 (Normal)
Min: 3
≤8 = Severe TBI → intubate!
9-12 = Moderate TBI
13-15 = Mild TBI

ET intubation if GCS ≤8: "8 = intubate"
Life-Threatening Thoracic Injuries — BATS CAMP
InjuryMechanismSignsDiagnosisTreatment
Tension PneumothoraxPenetrating or blunt; positive pressure ventilation (most common in intubated patients)Respiratory distress, absent breath sounds one side, tracheal deviation AWAY from injury, JVD, hypotension. Clinical diagnosis — do NOT wait for CXR!Immediate needle decompression: 2nd ICS midclavicular line (or 4th/5th ICS anterior axillary). Then chest tube.
Open PneumothoraxLarge chest wall defect (>2/3 tracheal diameter)Sucking chest wound, air movement through wound, paradoxical chest movementClinical3-sided occlusive dressing (allows air out, not in). Then chest tube at separate site. DO NOT tape all 4 sides (→ tension pneumo).
Massive HemothoraxPenetrating or blunt. Intercostal vessels or great vessels.Absent breath sounds, dullness to percussion, hypotension, shockCXR: opacification. Chest tube output >1500 mL initial OR >200 mL/hr for 3h = thoracotomyLarge-bore chest tube (36-40 Fr). Thoracotomy if massive (see above). Autotransfusion of blood.
Flail Chest≥3 consecutive ribs fractured in ≥2 places → free-floating segmentParadoxical chest wall motion (segment moves IN with inspiration). Hypoxia often from underlying pulmonary contusion (NOT just flail mechanics).CXR/CT: multiple rib fractures. ABG: hypoxiaAdequate analgesia (epidural preferred), PEEP/PPV to splint internally. Intubation if severe hypoxia. Surgical rib fixation for severe cases.
Cardiac TamponadePenetrating (stab > GSW), blunt, or iatrogenicBeck triad. Pulsus paradoxus. EMD/PEA on EKG.FAST exam (pericardial fluid). Echo: RV collapse.Pericardiocentesis (subxiphoid). Resuscitative thoracotomy in traumatic arrest. Emergency pericardial window.
Traumatic Aortic InjuryRapid deceleration (MVC, fall). Most tears at aortic isthmus (ligamentum arteriosum = fixed point).Widened mediastinum on CXR, unequal arm BP, sternal fracture, "apical cap," tracheal deviation rightCT angiography (gold standard). CXR screening.Permissive hypotension (SBP 80-90), BB (reduce dP/dt), TEVAR (endovascular stent graft) = standard of care. Open surgery for type A.
FAST Exam (Focused Assessment with Sonography for Trauma)

1. Pericardial

Subxiphoid view. Fluid between pericardium and heart → tamponade.

2. Right Upper Quadrant

Morrison pouch (hepatorenal space). Most dependent right-sided space → blood pools here first.

3. Left Upper Quadrant

Splenorenal space + perisplenic area. Harder to visualize than RUQ.

4. Pelvis (Pouch of Douglas)

Most dependent space in supine patient. Fluid here = significant bleeding.
E-FAST: Extended FAST adds bilateral lung views for pneumothorax (absent lung sliding = pneumothorax). Sensitivity 90%+ for significant hemoperitoneum. Positive FAST + unstable patient → OR immediately, no CT. Negative FAST + unstable → consider other causes (retroperitoneal, pelvic fracture, thoracic).
Matching — Trauma Injuries & Interventions

Match the trauma scenario (left) to the correct intervention (right):

Absent breath sounds on left, tracheal deviation RIGHT, JVD, hypotension after intubation
Chest tube (36Fr) + possible thoracotomy
GCS = 6, pupils unequal, decerebrate posturing
Needle decompression 2nd ICS MCL → chest tube
Dull to percussion, absent breath sounds, initial chest tube output 1800 mL blood
3-sided occlusive dressing + separate chest tube
Positive FAST exam, hemodynamically unstable despite 2L crystalloid
RSI + intubation, HOB 30°, neurosurgery consult
Sucking chest wound — air moving in and out of chest wall defect
Immediate OR — emergency exploratory laparotomy
UWorld/PANCE-Style Questions — Intro to Trauma

Question 1 of 6

A 28-year-old man arrives by ambulance after a high-speed MVC. He is unresponsive (GCS 6). During transport, he was intubated. In the ED, his BP drops to 70/40 and oxygen saturation is 82% despite 100% FiO₂. On exam, there are absent breath sounds on the right and the trachea is deviated to the LEFT. JVD is present. What is the immediate next step?
✅ B) Needle decompression of the right chest at 2nd ICS midclavicular line

This is tension pneumothorax — the classic post-intubation presentation. Positive pressure ventilation → air forced into pleural space without escape → increasing pressure collapses lung, shifts mediastinum AWAY, compresses great veins → JVD + hypotension + absent breath sounds on affected side + tracheal deviation AWAY from affected side.

This is a CLINICAL diagnosis — do NOT wait for CXR (patient will die). Immediate needle decompression at right 2nd ICS MCL → then chest tube. Trachea deviated LEFT = pathology on RIGHT (deflect = away from problem). ❌ CXR will delay treatment. ❌ FAST does not diagnose pneumothorax (use E-FAST for lung).

Question 2 of 6

A 19-year-old male is brought in after a stab wound to the left chest. His VS are BP 88/60, HR 128, RR 22. Exam reveals muffled heart sounds, jugular venous distension, and no breath sounds are absent bilaterally. A bedside FAST shows fluid in the pericardial space. What is the next step in management?
✅ C) Emergency pericardiocentesis or resuscitative thoracotomy

Penetrating chest trauma + Beck triad (JVD + muffled sounds + hypotension) + pericardial fluid on FAST = traumatic cardiac tamponade. This is a surgical emergency.

Pericardiocentesis (subxiphoid, needle) is a temporizing measure if patient is still alive
Emergency thoracotomy (ED thoracotomy) for penetrating chest trauma + loss of vital signs or imminent arrest = can be life-saving (open pericardium, control bleeding, internal cardiac massage)

Penetrating trauma (especially stab wounds) to the chest → think tamponade until proven otherwise. Stab wounds have better survival with ED thoracotomy than GSW because less destructive force. ❌ CT scan — do not delay definitive treatment. ❌ Chest tubes don't drain pericardial blood.

Question 3 of 6

A 40-year-old woman is brought in after an MVC. She has bruising over the left chest and complains of severe chest pain. Exam reveals paradoxical inward movement of the left lateral chest wall during inspiration. SpO₂ is 89% on 15L NRB. CXR shows multiple rib fractures of ribs 4-8 on the left in 2 places each, and a diffuse left lung infiltrate. What is the primary cause of her hypoxia?
✅ B) Underlying pulmonary contusion

This is flail chest (≥3 ribs fractured in ≥2 places = free-floating segment = paradoxical movement). However, the primary cause of hypoxia is NOT the mechanical flail movement — it is the underlying pulmonary contusion (alveolar hemorrhage/edema from the same force).

The diffuse left infiltrate = pulmonary contusion. Contusion causes V/Q mismatch → hypoxia that worsens over 24-48 hours. Management:
• Adequate analgesia (epidural ideal — allows breathing) to prevent splinting and atelectasis
• PEEP/positive pressure ventilation to pneumatically splint the segment
• Intubation if SpO₂ doesn't respond to O₂/NIV
• Fluid restriction (contusion worsens with overload)
• Avoid over-suctioning

Question 4 of 6

A 35-year-old male is brought in after a fall from a 20-foot ladder. He is confused and disoriented. GCS = 11 (E3V3M5). CT head shows a biconvex (lens-shaped) hyperdense lesion over the right temporal lobe with midline shift. He had a brief loss of consciousness followed by a "lucid interval" and then deteriorated. Which of the following is the most likely diagnosis?
✅ B) Epidural hematoma (EDH)

Classic presentation: Temporal/parietal blow → brief LOC → lucid interval → rapid deterioration → herniation. Mechanism: middle meningeal artery tear (runs in epidural space temporal bone). CT: biconvex/lens-shaped hyperdense (acute blood) lesion that does NOT cross suture lines (epidural space is limited by dural attachments at sutures).

Compare:
EDH: Biconvex, does NOT cross sutures, temporal, arterial bleeding, lucid interval
SDH: Crescent-shaped, CROSSES sutures, bridging vein tear, elderly/alcoholics, more gradual
SAH: "Worst headache of life," blood in cisterns/sulci, thunderclap onset

Treatment: Emergent craniotomy for EDH with midline shift/clinical deterioration. While prepping: elevate HOB 30°, mannitol 1g/kg IV, hyperventilate to pCO₂ 30-35 if herniation signs.

Question 5 of 6

A 58-year-old male presents after a rapid deceleration MVC. CXR reveals a widened mediastinum (>8 cm). He has a BP of 176/88 in the right arm and 148/70 in the left arm. There is no aortic regurgitation murmur. CT angiography shows a contained aortic injury at the isthmus with no extravasation. The patient is hemodynamically stable. What is the definitive treatment of choice?
✅ B) TEVAR (Thoracic Endovascular Aortic Repair)

Blunt aortic injury at the isthmus (most common location — at the ligamentum arteriosum, a fixed point between mobile arch and tethered descending aorta → maximum shear stress with deceleration). Contained injury (pseudoaneurysm) in stable patient → TEVAR is standard of care (superior to open surgery: less mortality, less paraplegia, faster recovery).

While preparing for TEVAR: anti-impulse therapy — IV esmolol/labetalol to reduce HR <80 and SBP 100-120 (reduces aortic wall stress and risk of rupture). If antihypertensive needed after HR control → sodium nitroprusside. ❌ Nicardipine alone = reflex tachycardia → worsens aortic shear stress. ❌ Observation only if truly minimal injury and patient refuses intervention.

Question 6 of 6

A 22-year-old male is involved in a drive-by shooting with a GSW to the abdomen. In the ED, his BP is 74/50, HR is 142. FAST exam shows free fluid in Morrison's pouch and the pelvis. You rapidly transfuse 2 units of PRBCs and his BP improves to 88/60. He remains tachycardic. According to hemorrhagic shock classification, what class of shock is he in and what is the most appropriate next step?
✅ B) Class III shock — activate MTP and prepare for OR

BP dropping to 74/50, HR 142, FAST positive (hemoperitoneum) = Class III hemorrhagic shock (30-40% blood volume loss, BP drops, confused/lethargic). Responds transiently to initial resuscitation but remains tachycardic = TRANSIENT RESPONDER → ongoing bleeding = needs definitive hemorrhage control (surgery).

Massive Transfusion Protocol (MTP): 1:1:1 ratio of PRBC:FFP:Platelets → damage control resuscitation (prevents dilutional coagulopathy, replaces all clotting factors, NOT just red cells). Avoid large crystalloid boluses (dilutes clotting factors, worsens "lethal triad" of hypothermia + acidosis + coagulopathy). Add TXA (tranexamic acid) within 3 hours of injury (reduces mortality).

❌ 4L crystalloid = outdated, harmful. Positive FAST + hemodynamic instability → OR immediately without CT.
Pre-Hospital Medicine — EMS, Triage, & Scene Management
EMS Provider Levels & Scope of Practice
LevelTrainingKey SkillsCannot Do
Emergency Medical Responder (EMR)40-60 hoursCPR, AED, basic airway (OPA, NPA), hemorrhage control, assisting higher-level providersIV access, medications (except assisting patient's own), advanced airway
EMT (Basic)100-150 hoursBVM ventilation, OPA/NPA, oxygen delivery, spinal immobilization, AED, tourniquet, patient assessment, assist with medications (epi-pen, nitroglycerin, albuterol, aspirin, oral glucose)IV access, cardiac monitoring, advanced airways, most medications
AEMT (Advanced)200-400 hoursAll EMT + IV/IO access, limited medication administration (D50, NS, epi IM for anaphylaxis), some advanced airwaysRSI, most cardiac medications, 12-lead interpretation (varies by state)
Paramedic1200-1800 hours (often AAS degree)All AEMT + 12-lead EKG interpretation, RSI/ETI, surgical airway, cardiac monitoring/cardioversion/pacing, broad medication formulary (epi, atropine, adenosine, amiodarone, morphine, fentanyl, versed, D50, thrombolytics in some systems)Surgical procedures beyond scope, physician-only procedures
Medical Direction

Online (Direct) Medical Direction

Real-time communication with a physician via radio/phone during patient contact.

Examples: Paramedic calls ED physician before giving thrombolytics in STEMI, asks permission for unusual doses, confirms withholding resuscitation.

Advantage: Flexibility for unusual situations, physician accountability.

Offline (Indirect) Medical Direction

Pre-established standing orders, protocols, and quality improvement programs developed by medical director.

Examples: Protocol to give aspirin to all chest pain patients, protocol to intubate GCS ≤8, standing order for epi in cardiac arrest.

Advantage: Speed — provider acts without calling for orders. Most prehospital care is protocol-driven.
START Triage (Mass Casualty Incident)
START = Simple Triage And Rapid Treatment — assess each patient in <30 seconds. Used for MCI when resources are overwhelmed. Tag colors: RED (Immediate), YELLOW (Delayed), GREEN (Minor/Walking Wounded), BLACK (Deceased/Expectant)
StepAssessmentFindingTag Color
1. Walking?Can patient walk to designated area?YES → walking woundedGREEN (Minor)
2. Breathing?Open airway — is patient breathing?NO breathing after repositioning → BLACK
YES breathing → go to step 3
BLACK (Deceased)
3. Respiratory RateCount breaths for 15 seconds × 4>30 breaths/min OR <10/min → RED
10-30 → go to step 4
RED (Immediate)
4. PerfusionRadial pulse OR capillary refillNo radial pulse OR cap refill >2 sec → RED
Pulse present + cap refill <2 sec → go to step 5
RED (Immediate)
5. Mental Status"Follow simple commands" (squeeze my hand, open eyes)Cannot follow commands → RED
Follows commands → YELLOW
RED or YELLOW (Delayed)
Expectant (BLACK) in living patients: In some MCI systems, patients who are unlikely to survive even with immediate care (devastating TBI, 90%+ BSA burns, multi-system failure) may be tagged BLACK to allow resources for salvageable patients. This is the hardest triage decision ethically.
SAMPLE History & Scene Assessment

📋 SAMPLE History

S — Signs & Symptoms
A — Allergies
M — Medications
P — Past medical/surgical history
L — Last oral intake
E — Events leading up to illness/injury

🚨 Scene Size-Up

1. Scene safety (BSI/PPE first!)
2. Nature of illness / Mechanism of injury
3. Number of patients
4. Additional resources needed?
5. C-spine considerations (trauma mechanism?)

🏥 OPQRST (Pain)

O — Onset
P — Provocation/Palliation
Q — Quality
R — Radiation
S — Severity (0-10)
T — Time (duration/course)

🧠 NEXUS Criteria (C-Spine)

Clear C-spine if ALL of:
• No midline tenderness
• Normal alertness
• No intoxication
• No focal neuro deficit
• No painful distracting injury
Fails ANY → cervical collar
Airway Management Progression (Field)
DeviceProviderIndicationKey Points
Positioning, Jaw ThrustAllBasic airway obstructionJaw thrust preferred in trauma (avoids neck extension)
OPA (Oropharyngeal)AllUnconscious, no gag reflexSize: corner of mouth to earlobe. Insert inverted, rotate 180°. Stimulates gag in conscious patients → vomiting.
NPA (Nasopharyngeal)AllConscious or semi-conscious, intact gagSize: tip of nose to earlobe. Lubricate. Contraindicated in basilar skull fracture.
BVM (Bag-Valve-Mask)AllApneic or inadequate breathingE-C clamp technique. 10-12 breaths/min adult. Use with supplemental O₂. 2-provider BVM preferred.
Supraglottic Airway (LMA, King LT, i-gel)AEMT/ParamedicCannot intubate, temporary airwayEasier to insert than ETT. Does not protect against aspiration as well. Used as rescue airway.
Endotracheal Intubation (RSI)ParamedicGCS ≤8, airway protection, respiratory failureConfirm with ETCO₂ (waveform capnography = gold standard) + CXR. RSI medications: etomidate + succinylcholine or rocuronium.
Surgical Airway (Cricothyrotomy)Paramedic (some systems)Cannot intubate, cannot oxygenate (CICO)Located between thyroid and cricoid cartilages. Needle crico (temporizing) → surgical crico. Contraindicated in children <12 (use needle only).
Matching — Pre-Hospital Triage & Scene Assessment

Match each scenario (left) to the correct START triage category (right):

Patient is ambulatory, walking to assembly area with minor lacerations and anxiety
BLACK — Deceased/Expectant
RR = 36/min, radial pulse absent, not following commands
GREEN — Minor (Walking Wounded)
Apneic despite airway repositioning maneuver; no spontaneous breathing
YELLOW — Delayed
RR = 18/min, radial pulse present, cap refill 1 sec, follows commands; has closed femur fracture
RED — Immediate
RR = 22/min, radial pulse present, cap refill <2 sec, follows commands; has painful forearm fracture
YELLOW — Delayed
UWorld/PANCE-Style Questions — Pre-Hospital Medicine

Question 1 of 6

A paramedic arrives at a mass casualty incident involving a building collapse. She finds a 45-year-old male who is not walking. He is breathing spontaneously with a rate of 34 breaths/min. His radial pulse is absent. Using START triage, what is the appropriate triage tag for this patient?
✅ C) Red — Immediate

START triage algorithm:
1. Walking? NO → continue
2. Breathing? YES → continue (not Black)
3. RR? 34/min = >30/min → RED immediately

Don't need to check further — RR >30 = RED regardless of circulation/mental status. The absent radial pulse would ALSO make him RED if we continued. He needs immediate intervention (control airway, stop bleeding, IV access, transport first).

Remember: In START, you assign a tag and MOVE ON — do NOT provide treatment beyond opening the airway. Treatment comes after all patients are triaged (unless you can correct a problem in <30 sec).

Question 2 of 6

An EMT is caring for a 68-year-old man with chest pain and diaphoresis. The patient has his own nitroglycerin prescription. His BP is 96/64 mmHg. He wants to take his nitroglycerin. What should the EMT do?
✅ B) Withhold nitroglycerin because the patient's BP is below 100 mmHg

EMTs can assist patients with their own prescribed nitroglycerin (cannot administer from their own kit). However, protocols typically require SBP ≥100 mmHg before assisting with nitroglycerin (vasodilation in hypotension → dangerous drop in BP → cardiogenic shock).

Also contraindicated: recent PDE-5 inhibitor use within 24-48 hours (sildenafil, tadalafil — severe hypotension).

At SBP 96 → withhold, lay flat, administer O₂, establish IV, rapid transport. ❌ Administer from own kit: EMTs do not carry nitroglycerin in their drug kit (paramedics do). ❌ Contact medical control and give anyway: contraindication exists regardless of online medical direction recommendation in many protocols.

Question 3 of 6

A paramedic is called to a scene where a 24-year-old female was found unresponsive in her apartment. Her roommate reports she "takes lots of medications." Exam reveals GCS of 6, pinpoint pupils, RR of 6/min, HR 54, and mottled, cool skin. She has track marks on both arms. Which intervention should be performed FIRST?
✅ B) OPA + BVM ventilation

Classic opioid overdose: pinpoint pupils + decreased LOC + respiratory depression (RR 6 = critical). Airway and breathing ALWAYS come first (ABCDE). RR 6 = respiratory failure → immediate BVM ventilation with OPA to maintain oxygenation/ventilation.

Then: IV/IO access → naloxone 0.4-2mg IV/IM/IN (can titrate). Naloxone reverses opioid-induced respiratory depression. Be prepared for acute withdrawal (agitation, vomiting) after naloxone. Repeated dosing or infusion may be needed (naloxone T½ shorter than most opioids).

❌ Don't rush to RSI before trying BVM + naloxone first — naloxone may restore spontaneous breathing, avoiding intubation. ❌ EKG is not the priority when someone is not breathing.

Question 4 of 6

A paramedic is transporting an intubated 55-year-old man in cardiac arrest who achieved ROSC 5 minutes ago. During transport, the patient's SpO₂ drops to 88% and EtCO₂ (waveform capnography) suddenly drops from 40 mmHg to 8 mmHg. Breath sounds are absent on the left. What is the most likely cause and the correct intervention?
✅ B) Right mainstem intubation — pull ETT back 1-2 cm

This is right mainstem bronchus intubation. When the ETT is advanced too far, it enters the right mainstem bronchus (straighter angle from carina) → only ventilates right lung → absent sounds on LEFT → desaturation.

The EtCO₂ dropped from 40 to 8 — initially might seem like arrest, but with ROSC and absent unilateral breath sounds, the cause is mechanical (tube position), not re-arrest. Waveform capnography remains positive (there IS ETCO₂, just low because only one lung ventilated).

Fix: Pull ETT back 1-2 cm, reassess breath sounds bilaterally, confirm with rising SpO₂. Correct ETT depth: ~3× ETT size in children, or at 21-23 cm at the lips in adults.

Tension pneumo would also cause absent breath sounds on one side, but typically with JVD, hypotension, and tracheal deviation — and would show more dramatic hemodynamic instability post-ROSC.

Question 5 of 6

EMS responds to a 58-year-old male with sudden onset crushing chest pain with radiation to the left arm, diaphoresis, and nausea. 12-lead EKG shows 3mm ST elevation in leads II, III, and aVF with reciprocal depression in I and aVL. The closest hospital with a catheterization lab is 65 minutes away. The closest hospital without cath lab is 12 minutes away. The patient is hemodynamically stable. What is the most appropriate prehospital destination decision?
✅ B) Transport directly to the PCI-capable hospital (65 min)

This is an inferior STEMI (ST elevation II, III, aVF = right coronary artery territory). Definitive treatment = primary PCI (door-to-balloon <90 minutes).

Guidelines: If first medical contact to balloon time ≤120 minutes is achievable by going directly to PCI center → bypass non-PCI hospital and go directly. 65 minutes transport + time in ED = still within 120 min window → bypass and go directly.

Pre-notification of receiving hospital reduces time to activation of cath team (cath team assembled before patient arrives). Give aspirin 324mg PO + heparin en route. ❌ Transfer from non-PCI hospital adds time (load-and-go → unload → re-load) often exceeding 120 min total. ❌ Field thrombolytics: only considered if PCI center is >120 min away AND patient is within 12 hours of onset with no contraindications.

Question 6 of 6

A paramedic responds to a 3-year-old child in cardiac arrest. CPR is in progress. The child weighs approximately 15 kg (per Broselow tape). The rhythm shows VF. What is the correct defibrillation dose and epinephrine dose for this child?
✅ B) Defibrillate 30J; Epi 0.15mg IV

PALS weight-based dosing for 15kg child:
Defibrillation: 2 J/kg first shock → 2 × 15 = 30J (subsequent shocks: 4 J/kg = 60J, max 10 J/kg or adult dose)
Epinephrine: 0.01 mg/kg IV/IO → 0.01 × 15 = 0.15mg (max 1mg)

Always use Broselow tape in pediatric codes — color-coded dosing avoids calculation errors under stress. Epinephrine concentration: use 1:10,000 solution (0.1 mg/mL) → 0.15mg = 1.5 mL of 1:10,000. Common pediatric error: using adult dose (1mg Epi) = 6.7× overdose → can cause severe hypertension, worsens outcomes.

VF in children is less common than asphyxial arrest (PEA/asystole) — always ensure airway/ventilation is optimized, as hypoxia is the most common cause of pediatric arrest.

Conduction Disorders — Rhythm Reference

Each rhythm is described by the 5-step analysis: Rate → Rhythm → P waves → PR interval (PRI) → QRS. Normal values: PRI 0.12–0.20 s (3–5 boxes), QRS <0.12 s (3 boxes). 6-second strip rate = R waves × 10.
⭐ Mechanism PearlIf the rhythm starts and stops suddenly → think reentry (AVNRT, VT post-MI). If it gradually speeds up and slows down → think automaticity (sinus tach). Triggered activity (afterdepolarizations) → Torsades. Conduction block → AV blocks.

Sinus & Atrial Rhythms

RhythmRateRhythmP wavesPRIQRSKey points
Normal Sinus60–100RegularPresent, upright, uniform0.12–0.200.08–0.10Baseline normal
Sinus Tachycardia100–150RegularPresent, upright, uniform0.12–0.200.08–0.10Treat underlying cause (fever, hypovolemia, anemia, PE, pain). Gradual onset; clear P waves
Sinus Bradycardia<60RegularPresent, upright, uniform0.12–0.200.08–0.10Athletes, BB, hypothyroid, ↑vagal tone. Symptomatic: Atropine → pacing → dopamine/epi
Sinus Arrhythmia60–100IrregularPresent, upright, uniform0.12–0.200.08–0.10Respiratory variation; benign, no treatment
Wandering Atrial Pacemaker60–100Regular≥3 morphologies0.12–0.200.08–0.10Multiple atrial foci, rate <100
Multifocal Atrial Tach (MAT)>100Irregular≥3 morphologies (varied)Variable0.08–0.10Classic in severe COPD; often mistaken for AFib. CCB/BB if LV preserved
⭐ Sinus Tach vs SVTSinus tach: gradual onset, usually <150, clear P waves, secondary to a cause. SVT: sudden onset, often >150–180, P waves hidden, reentry mechanism.

Sick Sinus Syndrome (Tachy-Brady)

SA node dysfunction — sinus arrest, SA exit block, or persistent bradycardia. Classic elderly presentation: recurrent SVT (often AFib) alternating with bradyarrhythmias. "The node is unreliable — sometimes it pauses, sometimes it races." Treating the tachyarrhythmia is difficult without first pacing (BB/CCB/antiarrhythmics worsen bradycardia). Permanent pacemaker = mainstay; does not reduce mortality but improves QOL.

Supraventricular Tachycardia (SVT)

Rate 150+ | Regular | P waves often non-discernable | QRS 0.08–0.10 (narrow). Paroxysmal SVT = sudden onset/offset, regular. Most common mechanism = reentry. AVNRT (dual AV nodal pathways) ≈ 60% of PSVT; AVRT (accessory pathway) ≈ 30%.

SVT Treatment ladder: 1) Vagal maneuvers (Valsalva at 45°, modified Valsalva w/ leg raise, diving reflex/cold water) → terminates 20–50%. 2) Adenosine 6 mg rapid IV push (1–2 s), then 12 mg if needed — terminates ~90%. Caution in reactive airway disease (bronchospasm). 3) If unstable or adenosine fails → synchronized cardioversion (100 J). Long-term: AV nodal blockers (BB/non-DHP CCB); catheter ablation preferred for recurrent symptomatic.

WPW / Pre-excitation

Accessory pathway → short PR + delta wave (slurred QRS upstroke). WPW syndrome = WPW pattern + SVT. 10-yr SCD risk 0.15–0.24%.

⚠ AVOID AV nodal blockers (CCB, BB, adenosine, digoxin) in WPW with AFib — blocking the AV node forces conduction down the accessory pathway → faster ventricular rates → can degenerate to VF. Use procainamide; cardiovert if unstable. Definitive Tx: catheter ablation.

Junctional & Premature Beats

RhythmRateP wavesQRSNotes
Junctional Escape40–60Inverted or absent0.08–0.10AV junction is pacemaker
Accelerated Junctional60–100Inverted or absent0.08–0.10
Junctional Tachycardia100+Inverted or absent0.08–0.10Causes: digitalis toxicity, myocarditis, CAD
PACEarly, different morphologyNarrowSingle ectopic atrial beat, irregular R-R
PJCInverted/absentNarrowSingle ectopic junctional beat
PVCNone (no P)WideBigeminy/trigeminy = every 2nd/3rd beat. Reassure if benign; eval if frequent/multifocal or >10% burden

AV Blocks

AV block = interruption of impulse from SA → AV node. PR interval is the key. Can be physiologic (↑vagal tone) or pathologic (ischemia, myocarditis, fibrosis, post-surgery).
BlockPRIPatternQRSLocation / RiskTreatment
1st degree>0.20 (fixed)Every P → QRSNarrowAV node; benignNone; treat reversible cause
2nd° Mobitz I (Wenckebach)Progressively lengthens"Longer, longer, drop"NarrowAV node; usually benignUsually observation
2nd° Mobitz IIConstantSudden dropped QRS; more P than QRSOften wideHis-Purkinje; high risk → complete blockPacemaker
3rd degree (complete)n/a (AV dissociation)P & QRS independentWide (escape)Infranodal; ventricular escape 20–40Transcutaneous pacing → permanent pacemaker

🧠 Heart Block Review

Prolonged PR (>200 ms); every P followed by QRS
2-I
Progressive PR lengthening → dropped QRS (Wenckebach)
2-II
Constant PR + occasional dropped QRS
AV dissociation — none conducted. Mobitz II & 3° → pacemaker. High-grade blocks = emergency

Ventricular Rhythms

RhythmRateQRSTreatment
Idioventricular (ventricular escape)20–40WideSeen post-MI reperfusion; usually none unless unstable
Ventricular Tachycardia100+Wide, no PStable: amiodarone. Unstable: synchronized cardioversion. Monomorphic (structural) vs polymorphic (ischemia/lytes)
Torsades de PointesTwisting around baselinePolymorphic VT + prolonged QT. Give magnesium! Defibrillate if unstable; correct lytes. QT-prolongers: antiarrhythmics, macrolides, fluoroquinolones, antipsychotics
Ventricular Fibrillationn/aFibrillatory, no organized QRSLethal — most common cause of SCD (~70% from CHD). Immediate defibrillation + CPR

Brugada Syndrome

Inherited Na+ channelopathy → SCD risk in young healthy people. More common in Southeast Asian males. ECG: ST elevation V1–V3. Presents with syncope/SCD. Treatment: ICD.

Atrial Fibrillation

Irregularly irregular | fibrillatory waves (no discrete P) | QRS narrow. Controlled 60–100; RVR 100+. Most common chronic arrhythmia (~50M globally). Multiple irritable atrial foci. Causes: HTN, valvular disease, dilated CM, ischemia, pulmonary disease, thyrotoxicosis (may be initial sign), "holiday heart" (alcohol). Types: paroxysmal (<7 d, self-terminating), persistent (>7 d, needs termination), permanent (>1 yr).

Major risk = thrombus (LA appendage) → stroke ~5%/yr untreated. AFib = 2× SCD risk, 5× HF risk.
Stable management = rate control + anticoagulation. Rate: BB (metoprolol, carvedilol), non-DHP CCB (diltiazem, verapamil), digoxin if BB/CCB contraindicated. Anticoagulation by CHA₂DS₂-VASc: ≥2 = chronic OAC; NOACs (apixaban, rivaroxaban, dabigatran, edoxaban) preferred over warfarin (INR 2–3). OAC ↓ embolic risk ~70%.
Cardioversion: if AFib >48 h or unknown duration → TEE first to exclude LA thrombus, OR ≥4 wks OAC before. Electrical: biphasic 200 J → 360 J. Continue OAC ≥4 wks post (often indefinitely). Unstable (shock, severe hypotension, pulmonary edema, ongoing ischemia) → urgent cardioversion despite thromboembolism risk.

Atrial Flutter

Sawtooth flutter waves (inferior leads II, III, aVF) | ratio variable (2:1, 3:1) | QRS narrow. One irritable atrial focus; atrial rate 250–350 bpm with AV block determining ventricular rate. Stroke risk = equivalent to AFib. Seen in COPD, VHD, ASD, repaired CHD. Catheter ablation = definitive; rate control (BB/non-DHP CCB), anticoagulation, cardioversion.

💡 Interactive ECG tracings with twelve diagnoses are in the 📊 EKG Quiz tab — use this tab as the written reference and that tab to test pattern recognition.

Hypotension

Definition: BP <100/60 in women or <110/70 in men. Etiologies: volume depletion, infection, medications, positioning/activity, pregnancy, cardiovascular disease.
First priority: RULE OUT SHOCK. Assess for multisystem hypoperfusion — markedly ↓BP, tachycardia, tachypnea, poorly perfused skin/extremities, altered mental status, ↓urine output. If no shock, consider SIRS, infection, liver failure, anaphylaxis, adrenal insufficiency, hemorrhage, PE, tamponade. Goal of treatment: perfused organs + treat underlying pathology.

Orthostatic Hypotension

Drop in SBP ≥20 mmHg or DBP ≥10 mmHg within 3 min of standing. Affects up to 24% of those >65.

Orthostatic vitals: lie flat 5 min → BP/HR; stand → BP at 1 and 3 min. Abnormal = SBP↓≥20, DBP↓≥10, + lightheadedness.

Causes: baroreflex dysfunction (neurodegenerative, neuropathy, aging), volume depletion (diuretics, hemorrhage, vomiting), antihypertensives, chronic HTN.

Symptoms: weakness, dizziness, visual blurring/darkening, syncope, cognitive slowing, occipital headache, neck pain. Complication: falls ± syncope.

Pharmacologic Options (OH)

ClassAgent
Alpha-1 agonistMidodrine
Alpha/Beta-adrenergic agonistDroxidopa
MineralocorticoidFludrocortisone
Acetylcholinesterase inhibitorPyridostigmine
SNRI(adjunct)
Patient education: stand slowly (sit → dangle legs → stand with support), avoid overheating/hot showers, hydrate, move legs when standing still, compression stockings, limit alcohol, feet up if faint.

Postprandial Hypotension

SBP fall ≥20 mmHg within 2 h of eating. Impaired baroreflex-mediated/splanchnic vasoconstriction. Meal modifications: avoid large meals, low-carb meals, avoid alcohol, drink water with meals, avoid sudden standing after eating, semi-recumbent 90 min post-meal if needed, walk between meals.

Vasovagal Syncope ("common faint")

Most common cause of syncope. Neural reflex → self-limited hypotension with relative/severe bradycardia ± vasodilation. Prodrome: lightheadedness, warmth/cold, sweating, palpitations, nausea, visual blurring/whiteout, "whooshing" sounds, pallor. Occurs sitting/standing; brief (1–2 min). Workup: ECG in all syncope; tilt-table confirmatory when atypical.

POTS — Postural Orthostatic Tachycardia Syndrome

Significant tachycardia within 10 min of standing WITHOUT postural hypotension. More common in women, age 20–50. May follow pregnancy, surgery, trauma, chemo, vaccination, or viral infection; associated with joint hypermobility & MVP.

Subtypes: neuropathic (peripheral denervation → venous pooling), hyperadrenergic (↑plasma norepinephrine), volume dysregulation (RAAS dysfunction), mast cell activation.

Non-pharm: volume repletion, high-salt diet, postural/psychophysiologic training, graduated exercise.
Pharm: Hyperadrenergic → BB (propranolol, metoprolol), clonidine, phenobarbital. Neuropathic → midodrine, droxidopa, pyridostigmine, fludrocortisone (same as OH).

Case Reviews

Case 1 — 76-y/o man with dizziness & "black spots" when standing, near-fall getting up from a chair. PMH: HTN, T2DM. Meds: lisinopril, HCTZ, metoprolol. Vitals: supine 132/78 HR 68; standing 1 min 108/66 HR 78; 3 min 106/64 HR 80.
Diagnosis: Orthostatic hypotension. SBP drops 132→106 (↓26, ≥20) on standing with only a blunted HR rise (baroreflex impairment in an older diabetic). Contributors: age, autonomic neuropathy from DM, volume depletion + vasodilation from HCTZ/lisinopril, rate-blunting from metoprolol. Risk: falls/syncope. Management: review/reduce offending meds, slow positional changes, hydration, compression stockings; consider midodrine/fludrocortisone if refractory.
Case 2 — 28-y/o woman with chronic dizziness, palpitations, fatigue shortly after standing; worse standing in line/after activity, better lying down; denies syncope. Viral illness 3 months ago. Vitals: supine 118/72 HR 72; standing (within 5 min) 116/70 HR 118. Exam normal.
Diagnosis: POTS. Marked tachycardia (HR 72→118, Δ46) on standing without a significant BP drop — distinguishes it from orthostatic hypotension (where BP falls). Often post-viral. Pathophysiology: venous pooling/denervation, hyperadrenergic response, or volume dysregulation. Non-pharm first: ↑salt & fluids, compression, graded exercise, postural training. Pharm by subtype: BB/clonidine (hyperadrenergic) or midodrine/fludrocortisone/pyridostigmine (neuropathic).

Lipid Disorders

⭐ Lipid HypothesisLDL is causal for ASCVD, not just a lab value. Lowering LDL slows plaque progression and stabilizes plaque. In established ASCVD, cholesterol lowering = secondary prevention → ↓mortality & recurrent events.

Lipoproteins (by density)

Triglyceride ↓density; apoproteins ↑density.

ParticleNote
ChylomicronsLeast dense; after fatty meals
VLDLVery low density
LDLCarries most cholesterol; ↑LDL = ↑ASCVD risk
HDLDensest/smallest; ↑HDL = ↓risk

Clinical Manifestations

Most patients asymptomatic. Hypertriglyceridemia → pancreatitis (esp. TG ≥500). May see xanthomas or xanthelasma (lipid plaques on eyelids).

Secondary causes: ↑TG/chol — alcohol, DM, obesity, CKD, diuretics, OCPs, steroids, hypothyroidism (↑total chol), nephrotic syndrome. ↓chol — cirrhosis, hyperthyroidism, malignancy.

Familial Hypercholesterolemia (FH)

Autosomal dominant/recessive → very high LDL → premature MI/CVA. ~1 in 500. Get family history + genetic testing in patients <40 with LDL >200. Treat: high-intensity statins or PCSK9 inhibitors; monitor for ASCVD closely.

When to Start a Statin

Use the ASCVD Risk Calculator. Initiate statin for: T1/T2 DM age 40–75 • No CVD, age 40–75, & 10-yr risk ≥7.5% • LDL ≥190 (age >21) • Any ASCVD • Age <19 with familial hypercholesterolemia history.

Statin Intensity

IntensityLDL ↓Agents
High≥50%Atorvastatin 40–80 mg • Rosuvastatin 20–40 mg
Moderate30–49%Atorva 10–20 • Rosuva 5–10 • Simva 20–40 • Prava 40–80 • Lova 40–80 • Pitava 1–4
Low~30%Simva 10 • Prava 10–20 • Lova 20 • Fluva 20–40 (rarely used)
When high-intensity: clinical ASCVD ≤75 y, LDL ≥190, DM + risk ≥20% (or 7.5–19.9%), primary prevention risk ≥7.5%, very high-risk ASCVD.
When moderate: ASCVD >75 y, intolerant to high-intensity, drug interactions / hepatic-renal dysfunction / East Asian heritage.
Statin monitoring/AEs: baseline LFTs + lipid panel, recheck lipids 4–12 wks. AEs: myalgias (most common), ↑LFTs, new-onset DM (esp. high-intensity), rhabdo (rare). Check CK for muscle symptoms. CI: active liver disease, pregnancy. Watch CYP3A4 interactions (atorva, simva, lova) — prava/rosuva have fewer.

Add-On / Non-Statin Therapy

AgentMechanismLDL/TG effectKey point
EzetimibeBlocks intestinal cholesterol absorptionLDL ↓13–25%First add-on when LDL ≥70 on max statin (IMPROVE-IT). Oral, cheap, proven CV benefit
PCSK9 inhibitors (evolocumab, alirocumab)mAb ↑LDL receptor expressionLDL ↓50–60%Very high-risk on statin+ezetimibe; FH. Injectable, expensive (FOURIER, ODYSSEY)
Inclisiran (siRNA)Silences PCSK9 productionLDL ↓48–52%Twice-yearly dosing; no CV outcomes data yet
Bempedoic acidATP-citrate lyase inhibitor (liver only)LDL ↓~24% monoStatin-intolerant patients; minimal muscle AEs (CLEAR). ↑gout/tendon rupture
Bile acid sequestrants (colesevelam)Bind bile acidsLDL ↓15–27%3rd-line; safe in pregnancy; ↓HbA1c. CI if TG >500. GI side effects
Icosapent ethyl (Rx EPA)Purified EPATG ↓20–30%ASCVD + TG 135–499 on statin (REDUCE-IT, 25% RRR). NOT the same as OTC fish oil
Fibrates (fenofibrate)PPAR-α agonistTG ↓30–50%Severe ↑TG (≥500) to prevent pancreatitis. No CV benefit added to statins; use fenofibrate not gemfibrozil w/ statin
Niacin↓lipolysis/VLDLTG ↓10–30%Largely abandoned — no CV benefit (AIM-HIGH, HPS2-THRIVE); flushing, hepatotox, ↑glucose

🧠 Best agent for each target

LDL
Statins (then ezetimibe → PCSK9i → bempedoic acid)
TG
Fibrates (≥500 to prevent pancreatitis); icosapent ethyl if ASCVD + TG 135–499
HDL
Niacin (raises HDL but no proven CV benefit)

Practice Cases

Case 1 — 58-y/o man with HTN, T2DM, obesity. Lipids: TC 245, LDL 160, HDL 40, TG 180. Most appropriate first-line treatment?
A) Statin B) Fibrate C) Omega-3 D) Ezetimibe
A) Statin therapy. Diabetic 40–75 with elevated LDL → statin is first-line (likely high-intensity given DM + risk factors). Ezetimibe is an add-on, not first-line.
Case 2 — 45-y/o woman, family history of hyperlipidemia, LDL 195, TC 275, HDL 55, normal TG. Most likely diagnosis?
A) FH B) Hypothyroidism C) Metabolic syndrome D) ASCVD
A) Familial hypercholesterolemia. Isolated very high LDL with strong family history and normal TG/HDL points to FH. Treat with high-intensity statin ± PCSK9i.
Case 3 — 68-y/o man, MI 3 yrs ago, on atorvastatin. LDL 98, TC 160, HDL 40, TG 120. Which is true?
A) LDL at target for secondary prevention B) Stop statin C) High risk — further LDL lowering indicated D) Needs HDL therapy
C) High risk — further LDL lowering indicated. Established ASCVD = very high risk; goal LDL <70 (often <55). At LDL 98 on statin → add ezetimibe ± PCSK9i.
Case 4 — 32-y/o woman with muscle aches/weakness after starting atorvastatin 20 mg. Which test for the statin-related side effect?
A) LFTs B) TFTs C) CBC D) CK
D) Creatine kinase (CK). Myalgias are the most common statin AE; CK assesses for myopathy/rhabdomyolysis.
Case 5 — Recurrent pancreatitis, TG 800. Best agent to lower TG?
A) Gemfibrozil B) Atorvastatin C) Ezetimibe D) Niacin
A) Gemfibrozil (fibrate). Severe hypertriglyceridemia (≥500) → fibrate to prevent pancreatitis. Statins/ezetimibe mainly lower LDL.

Shock

Shock = circulatory failure — arterial blood flow inadequate for tissue metabolic needs → regional hypoxia → lactic acidosis → end-organ damage. Goal MAP >65 mmHg; MAP <65 = shock.

Hemodynamic Equations

MAP = CO × SVR
MAP = DBP + ⅓(SBP − DBP)
CO = HR × SV
SV = Preload × Contractility

MAP ≥65 needed to perfuse vital organs. SVR (tone) determines DBP — ↑tone = ↑DBP.

Identifying Shock

Vitals first: SBP <90, tachycardia, tachypnea. Shock Index = HR ÷ SBP; SI >0.9 predicts mortality and need for pressors/fluids/blood.

Narrowed pulse pressure = early sign of hemorrhagic shock (↑SVR → ↑DBP). SvO₂ normal 65–75% (low = inadequate delivery; high in sepsis from impaired extraction).

Physical exam (ABCDE): Airway patency (tracheal deviation = tension); Breathing (equal bilateral, ↓sounds = blood/pneumo); Circulation (pulses, stop bleeding, JVD = obstructive, cool vs warm); Disability (GCS <8 → intubate; deficits/priapism = neurogenic); Exposure (infection, bleeding, temp). Cool/clammy = obstructive/hypovolemic/cardiogenic; warm/dilated = distributive.

The Four Classifications

TypeMechanismSkin / JVPKey causesTreatment cornerstone
Hypovolemic↓intravascular volume (↓preload)Cold; low JVP, narrow PPHemorrhage (trauma, GI bleed, AAA, ectopic), burns, vomiting/diarrheaGive back volume — stop bleeding, IVF then blood
CardiogenicPump failure / ↓contractilityCold; ↑JVP, pulmonary edemaMI (most common), cardiomyopathy, valvular, arrhythmiaPCI, pressors (NE), inotropes (dobutamine/milrinone), IABP/VAD
ObstructiveObstruction of venous return/COCold; ↑JVP/CVPTension pneumothorax, tamponade, massive PERelieve obstruction — needle decompression / pericardiocentesis / thrombolysis
DistributiveInappropriate vasodilation (↓SVR)Warm, wide PP, hyperdynamicSepsis (most common), anaphylaxis, neurogenic, adrenal/endocrineIVF + vasopressors (NE) + treat cause

Hypovolemic Shock

↓preload from blood/fluid loss. Cold-shock picture, low JVP, narrow PP, oliguria, AMS. Labs: Hgb/Hct (trends best — may be normal early), BUN:Cr >20 (prerenal), lactic acidosis, coagulopathy in severe hemorrhage. Imaging: CXR/PXR, FAST exam, CT if stable. Treatment: stop the bleeding → isotonic IVF → blood (type O-neg or type-specific PRBCs/whole blood). Monitor response: urine output, BP, HR, mental status, warmth, cap refill, pH/base deficit/lactate.

Cardiogenic Shock

Tissue hypoxia from ↓CO despite adequate volume. ↑JVP, pulmonary edema. Echo: ↓LV contractility, dilated/full LV (vs small hyperdynamic LV in hypovolemia). ECG for ischemia (STEMI = ≥1 mm in ≥2 contiguous leads; troponin for NSTEMI/UA). Treatment: ABCs, careful IVF (250 mL challenges), pressors to MAP 65 (norepinephrine 1st-line; milrinone lowers SVR), PCI mainstay for MI, inotrope dobutamine (low CO + high PCWP, no hypotension), mechanical support (IABP, VAD).

Obstructive Shock

↑CVP but ↓LV filling. Tension pneumothorax: trachea deviated away, ↓breath sounds, distended neck veins → needle decompression + chest tube. Tamponade: Beck's triad (JVD, muffled sounds, hypotension), narrow PP, patient leaning forward → pericardiocentesis. Massive PE: sinus tach (most common ECG), classic S1Q3T3 in minority → anticoagulation/thrombolysis/embolectomy.

Distributive Shock

Warm extremities, wide PP, hyperdynamic LV.

Septic shock (most common, 20–50% mortality): sepsis + fluid-unresponsive hypotension + lactate >2 + needing pressors for MAP >65. Treatment: 1) Volume — 30 mL/kg crystalloid in first 3 h; 2) Broad-spectrum antibiotics within 1 h (cultures first; mortality ↑10%/hr delay); 3) Pressors — norepinephrine 1st-line, add vasopressin 0.01–0.04 U/min. SIRS ≥2: temp >100.4/<96.8°F, HR >90, RR >20, abnormal WBC.
Neurogenic: spinal cord injury → loss of sympathetic tone → hypotension + bradycardia (no compensatory tachycardia), warm. IVF + pressors to MAP 85–90 for spinal perfusion (rule out hemorrhage first). Anaphylactic: IgE-mediated vasodilation, angioedema, bronchospasm → IM epinephrine 0.3–0.5 mg q5–15 min, IVF, H1+H2 blockers, albuterol, steroids. Endocrine: adrenal insufficiency (abrupt steroid cessation), myxedema, thyroid storm.

Vasopressors & Inotropes

AgentActionUse
Norepinephrineα > β1 (↑MAP)1st-line: septic, cardiogenic, neurogenic shock
Epinephrineα + βVasopressor of choice for anaphylaxis; severe shock/resuscitation
PhenylephrinePure αHyperdynamic septic shock when tachyarrhythmia limits β-agents
VasopressinV1 vasoconstrictionAdjunct to NE in distributive shock
DopamineDose-dependent (dopa→β→α)Alternative pressor; bradycardia
Dobutamineβ1 inotrope, ↓afterloadLow CO + high PCWP without hypotension (cardiogenic)
MilrinoneInotrope, lowers SVRCardiogenic shock (PDE-3 inhibitor)
⭐ Volume FirstVasoactive agents are given only after adequate fluid resuscitation. Continued hypotension with high CO (sepsis) → pressors. Low CO with high filling pressures → inotropes. Septic = 30 mL/kg; cardiogenic = small 250 mL boluses; give less to HF/CKD patients.

Cardiovascular Emergencies — Approach to Chief Complaints

Emergency approach (ABCDE): Airway → Breathing (resp failure, pulmonary edema) → Circulation (shock, arrhythmia, tamponade) → Disability (AMS = hypoxia/low perfusion/stroke) → Exposure (fever, trauma, infection). Always assess vitals, mental status, oxygenation, hemodynamic stability. Stabilize → risk-stratify → diagnose.
Red flags & "until proven otherwise": Hypotension = shock • Syncope + exertion = structural/arrhythmia • Chest pain + diaphoresis = ACS • Dyspnea + JVD = HF/tamponade/PE • Palpitations + syncope = malignant arrhythmia • Orthopnea = decompensated HF. Plus: AMS, hypoxia, new arrhythmia, ST elevations, JVD + hypotension.

Chest Pain / Angina

Can't-miss: ACS (STEMI/NSTEMI/UA), aortic dissection, PE, tension pneumothorax, tamponade, esophageal rupture, myocarditis, stress cardiomyopathy, perforated ulcer. History: OPQRST + diaphoresis/nausea/dyspnea/syncope.

Dx: ECG within 10 min, troponin, CXR (edema, pneumo, widened mediastinum), CBC/CMP/Mg, ±D-dimer. Mgmt: O₂ if hypoxic, aspirin, nitroglycerin (not if hypotensive or RV infarct), IV access, monitoring.

⭐ PearlsAll chest pain is cardiac until proven otherwise. Normal ECG ≠ no ACS. Troponin = injury, not mechanism. NTG response doesn't rule in/out ACS. Epigastric pain can be MI. Women/elderly/diabetics atypical.

Dyspnea on Exertion

Can't-miss: HF, ACS, valvular (AS, MS), PE, arrhythmia. History: acute vs chronic, positional, exertional threshold, weight gain, orthopnea/PND, edema.

Dx: ECG, BNP, CXR (congestion, effusions), CBC/CMP/Mg, ±echo. Mgmt: O₂ if hypoxic, diuretics if overloaded.

⭐ PearlsDyspnea is often cardiac, not pulmonary. DOE = early HF sign. Orthopnea = ↑LV filling pressures. Crackles are LATE; JVD is earlier. PE often = normal CXR + hypoxia.

Palpitations

Can't-miss: VT and other malignant arrhythmias. Dx: ECG (rhythm), electrolytes, TSH, drug screen. Mgmt: monitoring; unstable → synchronized cardioversion; stable → rate/rhythm control.

⭐ PearlsRate kills before rhythm. Hypotension in tachyarrhythmia = unstable → electricity, not meds. AFib w/ RVR → cardiogenic shock. Wide-complex tachycardia = VT until proven otherwise.

Syncope

Can't-miss: arrhythmia, aortic stenosis, HCM, PE, tamponade, hemorrhage. High-risk: exertional syncope, no prodrome, family history of sudden death, structural disease. Dx: ECG, glucose, orthostatics, troponin, electrolytes, TSH, drug screen.

⭐ PearlsCardiac syncope = highest mortality. Exertional = obstruction/arrhythmia. No prodrome = arrhythmia. Family hx sudden death = genetic cardiomyopathy. Syncope is a diagnosis of cause.

Edema

Pitting vs non-pitting; unilateral vs bilateral. Cardiac causes: HF, constrictive pericarditis, VTE. Red flags: rapid onset (acute HF/PE), dyspnea, hypotension (cardiogenic shock), ascites + JVD (R-sided HF). Dx: CMP, BNP, venous US (DVT), ±echo.

⭐ PearlsBilateral = systemic until proven otherwise. Unilateral = DVT until proven otherwise. JVD + edema = cardiac. Ascites + edema = advanced R-sided failure.

Orthopnea

Can't-miss: HF, cardiomyopathies, pulmonary edema, pericardial effusion. Pathophys: ↑venous return → pulmonary congestion. Strong predictor of HF decompensation. Workup like dyspnea (JVD, crackles, murmurs, S3/S4, edema, tripoding).

🧠 Quick Guide — "until proven otherwise"

CP
Chest pain → ischemia
SOB
Dyspnea → HF/PE
Syncope → arrhythmia
Palpitations → electrical instability
💧
Edema → heart failure • Orthopnea → pulmonary congestion
ER survival rules: Rule out lethal causes first. Treat instability immediately (electricity > meds when unstable). Think in syndromes & physiology. Reassess after every intervention. Never trust a single data point. Ask "what will kill this patient fastest?" Avoid anchoring/confirmation bias. Normal vitals ≠ stable physiology.

Case Studies

Case 1 — "Pressure and Doom" 62-y/o man, 30 min crushing substernal pressure radiating to left arm/jaw, diaphoretic, nauseated. BP 88/54, HR 112, RR 24, SpO₂ 91% RA. HTN, HLD, T2DM, 40-pk-yr smoking.
Red flags: hypotension (shock), hypoxia, classic ACS presentation. Can't-miss DDx: STEMI/ACS (top), aortic dissection, PE, tamponade. Dx: ECG within 10 min, troponin, CXR (mediastinum), CBC/CMP. Mgmt: aspirin, O₂, IV access, monitoring — avoid nitroglycerin (hypotensive, possible RV involvement); this is cardiogenic shock from likely STEMI → activate cath lab / PCI, cautious fluids, pressors (norepinephrine).
Case 2 — "I can't breathe lying down" 70-y/o woman, 3 days worsening SOB, can't lie flat, sleeping in chair. BP 104/66, HR 108, RR 26, SpO₂ 89% RA. JVD, bilateral crackles, S3, pitting edema. CHF, prior MI, CKD.
Red flags: hypoxia, orthopnea, JVD. Dx: decompensated heart failure (acute pulmonary edema). DDx: ACS trigger, arrhythmia. Dx workup: ECG, BNP, CXR, troponin, CMP. Mgmt: O₂/positioning (consider NIPPV), IV loop diuretics, nitrates if BP tolerates; identify precipitant (ischemia, arrhythmia, nonadherence).
Case 3 — "Passed out at work" 28-y/o man collapses after sudden palpitations, brief LOC. BP 92/60, HR 168 irregular, RR 22, SpO₂ 96%. No PMH. Father died suddenly at 41.
Red flags: syncope + palpitations + exertion, no prodrome, family history of sudden cardiac death → malignant arrhythmia / genetic cardiomyopathy (HCM, WPW, Brugada, channelopathy). Irregular wide/fast rhythm — consider AFib with pre-excitation (WPW). Dx: 12-lead ECG (delta wave?), electrolytes, TSH, troponin, echo. Mgmt: monitoring; borderline-unstable → prepare for synchronized cardioversion; if WPW + AFib AVOID AV nodal blockers.
Case 4 — "Swollen Legs" 66-y/o man, 2 wks progressive bilateral leg swelling + worsening DOE. BP 98/64, HR 102, RR 22, SpO₂ 92%. Massive pitting edema, hepatomegaly, JVD, ascites. COPD, pulmonary HTN, OSA.
Red flags: JVD + bilateral edema + ascites + hepatomegaly = right-sided heart failure / cor pulmonale (from COPD + pulmonary HTN + OSA). DDx: constrictive pericarditis, tamponade. Dx: BNP, echo (RV function, PA pressures), CMP, ECG. Mgmt: diuresis, O₂, treat underlying pulmonary HTN/OSA.

Case Study: "The Fever That Won't Go Away"

Work through this infective endocarditis case as a clinical reasoning exercise. Reveal each answer after you've thought it through.

Part 1 — Presentation

32-y/o man: "Fever and body aches for ~2 weeks, feel exhausted." Temp 38.6°C (101.5°F), HR 112, BP 104/64, RR 18, SpO₂ 97%. Reports progressive fatigue, intermittent fevers/chills, night sweats, ↓appetite, mild exertional dyspnea, diffuse joint aches. Thought it was "the flu."

Task 1: What critical history questions are needed?
Recent dental procedures; IV drug use; prosthetic valves / prior IE; indwelling catheters; congenital heart disease; recent infections; travel/exposures; embolic symptoms (vision changes, stroke); dyspnea/chest pain; hematuria/flank pain; weight loss/night sweats. Teaching point: transient bacteremia occurs after dental & invasive procedures.

Part 2 — Expanded History

Dental extraction 3 weeks ago • History of IV heroin use, last injection 1 month ago • No known heart disease • New: sharp right-sided pleuritic chest pain, dry cough, intermittent abdominal discomfort.

Task 2: Key risk factors & top differentials?
Risk factors: IV drug use, recent dental procedure. DDx: Infective endocarditis (fever + IVDU + dental work — leading), pneumonia (fever, infiltrates), myocarditis, pulmonary emboli (pleuritic pain), TB (night sweats, but acute timeline argues against). Suspicion shifts strongly toward IE.

Part 3 — Physical Exam

Appears ill/fatigued. Cardiac: tachycardia, new holosystolic murmur at LLSB. Skin: small painless erythematous macules on palms/soles; linear reddish-brown streaks under nails. Lungs: scattered RLL crackles. Eyes: retinal hemorrhages with pale centers.

Task 3: Classic findings & leading diagnosis?
Classic IE stigmata: Janeway lesions (painless palm/sole macules), splinter hemorrhages (nail streaks), Roth spots (retinal hemorrhage with pale center), new murmur (valvular involvement). LLSB holosystolic murmur ↑ with inspiration = tricuspid regurgitation. Leading dx: right-sided (tricuspid) infective endocarditis — typical for IVDU.

🧠 FROM JANE — IE peripheral signs

F
Fever
R
Roth spots (retinal hemorrhages, pale center)
O
Osler nodes (painful, fingertips/toes)
M
Murmur
J
Janeway lesions (painless palms/soles)
A
Anemia
N
Nail-bed (splinter) hemorrhages
E
Embolism (septic pulmonary emboli in right-sided IE)
Task 4: What diagnostic studies?
Blood cultures ×2–3 BEFORE antibiotics (essential), echocardiogram (TEE > TTE for vegetations), CBC (leukocytosis), ESR/CRP (inflammation), ECG (conduction abnormalities/abscess), CXR (septic pulmonary emboli).

Part 5 — Results

WBC 16,500 (↑), ESR/CRP elevated, Cr normal, UA: microscopic hematuria. TTE: mobile vegetation on tricuspid valve. ECG: sinus tach. CXR: multiple patchy pulmonary infiltrates. Blood cultures pending.

Task 5: Apply the Duke Criteria — does he meet them?
Major: positive blood cultures (later confirmed) + vegetation on echo. Minor: fever >38°C, IV drug use (predisposing), vascular phenomena (septic pulmonary emboli), immunologic phenomena (Roth spots, hematuria/glomerulonephritis). → DEFINITE infective endocarditis (2 major, or 1 major + multiple minor).

Part 6 — Cultures (48 h)

Blood cultures grow MRSA (methicillin-resistant Staphylococcus aureus).

Task 6: Complete treatment plan?
Admit (all IE patients). Empiric: Vancomycin IV + Ceftriaxone IV. Targeted (MRSA): continue IV Vancomycin × 4–6 weeks. Consults: Infectious Disease (ALL cases), Cardiology, Cardiac Surgery if needed. Surgical indications: acute HF, persistent infection after 7–10 days, recurrent emboli, fungal infection, abscess formation.
Task 7: Counseling?
Harm reduction: substance-use treatment referral, avoid IV drug use. Antibiotic prophylaxis for future dental work (indicated given history of IE). Complications to watch: embolic events, HF, recurrence. Long-term follow-up with cardiology/ID.
Cardio Quiz #3 — Hard Final Review
Interactive timed final-review quiz with explanations, topic filters, and scoring. Use the controls inside the quiz to start the timer or review explanations.